[
    {
        "pmid": "40818547",
        "title": "Biophysical analysis of an oligomerization-attenuated variant of the Leishmania donovani dynamin-1-like protein.",
        "abstract": "Chemotherapy cornerstone battle leishmaniasis neglected tropical disease caused Leishmania parasite affect million worldwide alarming number report describing treatment failure currently available drugs thereby explaining dire need discovery novel compounds preferably yet unexplored mode action respect L donovani dynamin1 like protein LdoDLP1 interest mutation LdoDLP1 recently shown confer resistance new antileishmanial compound suggesting potential drug target combination biochemical structural biophysical methods able show wildtype LdoDLP1 strong inherent propensity selfassemble higherorder oligomers Guided structural modeling selection nine point mutation including resistance markers screened oligomerization behavior generate selfassembly impaired LdoDLP1 mutant would occur solution dimer andor tetramers led identification double mutant G354DR357S exhibit significantly altered reduced yet completely abolished oligomerization behavior characterization LdoDLP1 G354DR357S double mutant using smallangle Xray scattering SAXS revealed fraction protein population occurs dimer solution Additionally SAXS analysis experimentally confirmed LdoDLP1 like dynaminlike proteins lack structurally defined pleckstrin homology PH domain classical dynamins instead possesses intrinsically disordered B insert grouping among dynaminlike protein play key role process mitochondrial fission",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818547/",
        "source_type": "Global"
    },
    {
        "pmid": "40808943",
        "title": "Protein dysregulation during <i>Leishmania infantum</i> infection in anti-TNF immunosuppressed mice revealed through quantitative proteomics analysis of extracellular vesicles.",
        "abstract": "Visceral leishmaniasis VL occurs frequently immunosuppressed individuals especially undergoing immunosuppressive drug therapy autoimmune disease receiving TNF antagonist therapy antiTNF course VL severe response traditional leishmanicidal treatments antimonials Sb often reduced effect antiTNF treatment observed immunosuppressedmouse model VL model compared antiTNF immunosuppression immunosuppression VL treatment Sb Serumderived extracellular vesicle EVs analyzed labelfree quantitative proteomics identify protein involved VL severity impact antiTNF immunosuppression treatment outcome total 223 dysregulated protein found pretreatment groups majority which vitronectin haemopexin caveolin1 downregulated antiTNF samples contrast 173 protein identified Sbtreatment groups found enriched antiTNF plus treatment sample antiTNFSb including fibronectin transferrin vitronectin dipeptidyl peptidase4 differentiallyexpressed protein associated pathway related immune system liver regeneration ion transport finding useful implication clinical management VL patient antiTNF immunosuppression",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808943/",
        "source_type": "Global"
    },
    {
        "pmid": "40799923",
        "title": "Rare detection of dermal <i>Leishmania infantum</i> in two pediatric patients with cutaneous leishmaniasis (CL) in southern Iran.",
        "abstract": "study highlight rare detection dermal iLeishmania infantumi two pediatric patient cutaneous leishmaniasis CL southern Iran patient history visceral leishmaniasis VL presented atypical facial lesions Molecular assay confirmed presence L iinfantumi specie PCR targeting cysteine protease B cpb gene revealing 702741bp amplicons Phylogenetic analysis describes two pediatric CL case southern Iran caused strain L iinfantumi closely related LIPA59 genotype detection immunocompetent child challenge traditional association L iinfantumi solely VL highlight capacity atypical dermal manifestations finding underscore necessity molecular diagnostics differentiate iLeishmaniai species misidentification risk ineffective treatment potential disease progression Enhanced surveillance integrating PCRbased method critical track dermal strain region VL CL overlap particularly given potential ecological genetic driver atypical tropism Addressing emerging threat requires integrated strategy mitigate dual burden cutaneous visceral disease vulnerable populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799923/",
        "source_type": "Global"
    },
    {
        "pmid": "40797335",
        "title": "Microbial diversity in cutaneous leishmaniasis lesions and potential implications for disease progression and treatment outcomes.",
        "abstract": "Beyond parasitic infection Cutaneous leishmaniasis CL secondary bacterial colonization influence disease chronicity delay healing reduce treatment efficacy study investigated bacterial diversity CL lesions association lesion duration potential impact treatment outcome among Sri Lankan patients Fifteen bacterial specie identified including Grampositive Gramnegative organisms Staphylococcus aureus associated longest lesion duration up 12 months extended treatment 15 cycle intralesional sodium stibogluconate cryotherapy contrast specie Kocuria palustris Acinetobacter baylyi linked shorter treatment durations Multivariate analysis revealed lesion type significantly influenced treatment duration P  005 larger lesion size diabetes showed marginal association prolonged therapy presence opportunistic antibioticresistant species particularly S aureus suggests potential contributory role bacterial coinfections CL progression highlight need consider presence treatment planning Integrating microbial profiling clinical protocol may enhance treatment efficacy inform personalized care strategies However limited sample size conveniencebased recruitment may affect generalizability findings potential influence bacterial colonization treatment response warrant investigation larger cohorts",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797335/",
        "source_type": "Global"
    },
    {
        "pmid": "40796014",
        "title": "Lymphatic-targeted amphotericin B nanocrystals delivered using microarray patches applied to cutaneous leishmaniasis.",
        "abstract": "Leishmaniasis parasitic disease transmitted female sandflies primarily affect impoverished population tropical subtropical regions Cutaneous leishmaniasis CL prevalent form 600000 new case annually Leishmania parasite spread via lymphatic system leading disease progression Amphotericin B AmB shown efficacy Leishmania spp yet cause renal toxicity requires intravenous administration posing challenge resourcelimited settings study explores intradermal delivery AmB nanocrystals NCs via dissolving microarray patch MAPs enhance lymphatic uptake AmBNCs formulated using medium milling achieving mean particle size 108 ± 4 nm vitro study showed faster dissolution potent antileishmanial activity lower host cell toxicity Ex vivo study demonstrated MAPmediated intradermal drug deposition 247 ± 25 μg049 cmsup2sup vivo rat study revealed MAPs achieved 32fold 28fold higher AmB accumulation axillary lumbar lymph nodes respectively compared commercial formulation IV AmBisome® p  005 Reduced liver spleen kidney accumulation suggests lower organ toxicity AmBNCs MAPs present promising minimally invasive alternative CL treatment enhancing lymphatic targeting reducing healthcare burdens addressing key barrier effective treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796014/",
        "source_type": "Global"
    },
    {
        "pmid": "40794782",
        "title": "Transcriptome profiling of L. infantum-infected human macrophages reveals sex-specific type I interferon induction.",
        "abstract": "Sexbased difference immune system influence clinical course infectious diseases including many parasitic infections Field study human infection controlled experimental rodent model shown certain clinical form leishmaniasis occur frequently males Leishmania parasite infect proliferate innate immune cells particularly macrophages modulate early immune response constrain survival replication study used highthroughput vitro system assess sex difference human macrophagespecific immunity Leishmania L infantum infection Quantification infection showed significantly higher infection rate parasite load macrophage derived men compared woman 76 hour postinfection hpi Evaluation macrophage phenotype L infantum infection revealed minor change proportion primarily proinflammatory M1like macrophages whereas reduction antiinflammatory M2like phenotype observed sexes Cytokine profiling revealed elevated level TNF IL8 IL10 reduced level IL18 CCL2 culture supernatant time infection Transcriptomic analysis showed highest adaptation gene expression 6 hpi pronounced femalederived macrophage 1428 downregulated2145 upregulated genes compared malederived macrophage 972 downregulated1637 upregulated genes gradually decreased time sexes Genes associated type interferon response eg IFIT2 IFIT3 IFIT5 OASL JAK1 specific cytokine response IL15 IL1R1 matrix metalloproteinase MMP9 upregulated female macrophages gene encoding proinflammatory chemokines involved immune cell recruitment CXCL1 CXCL3 CCL20 CCL7 upregulated male macrophages Treatment infected macrophage estradiol conferred marginal resistance infection femalederived macrophages whereas testosterone treatment effect summary finding reveal immune mediator underscore biological sex difference may explain females superior ability combat Leishmania infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794782/",
        "source_type": "Global"
    },
    {
        "pmid": "40794727",
        "title": "Putting behaviors into context for vector-borne diseases: Examining behaviors that may reduce exposure to disease vectors.",
        "abstract": "Understanding people adopt ignore vectorborne disease VBD preventive measure key better risk assessment control However little known household adopt preventive practice others not particularly striking era One Healths attention human environmental animal health examined household factor linked practice may reduce exposure disease vectors focus Chagas disease CD American Cutaneous Leishmaniasis ACL vectors surveyed 204 household 12 rural community Coclé Province Republic Panama March 2022 December 2023 used logistic regression model explore association household contextual elements respondents sex wealth consumer good agricultural knowledge ACL CD feeling insects perception control health outcomes personal use repellents hand protection touching CD vector propertybased behavior use insecticide house use windowsdoors screens cleaning peridomestic debris may reduce exposure disease vectors found mixed association protective behavior contextual household elements Participants reported feeling bothered insect likely use repellent Odds Ratio OR 297 95 Confidence Interval 95CI 147620 whereas reported control health less likely use protection touching CD vector OR  08 CI 067095 Windowdoor screen associated household consumer good wealth OR 144 CI 123171 household history ACL case likely peridomestic debris accumulation OR 233 CI 117475 Additionally householder bothered insect less likely peridomestic debris OR 042 CI 020084 well believe health outcome happen chance OR 089 CI 082098 finding emphasize importance considering comprehensive household background attention cultural value foster contextsensitive strategy vectorborne pathogen prevention control",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Animals",
            "Vector Borne Diseases",
            "Chagas Disease",
            "Adult",
            "Middle Aged",
            "Panama",
            "Rural Population",
            "Leishmaniasis, Cutaneous",
            "Young Adult",
            "Health Knowledge, Attitudes, Practice",
            "Family Characteristics",
            "Surveys and Questionnaires",
            "Adolescent",
            "Aged",
            "Insect Vectors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794727/",
        "source_type": "Global"
    },
    {
        "pmid": "40786644",
        "title": "Cutaneous leishmaniasis in a renal transplant patient: Diagnostic challenges in a non-endemic setting.",
        "abstract": "Leishmanial infections though uncommon Southeast Central Asia remain clinically significant due potential cause substantial morbidity mortality case report present young Nepalese male four year postrenal transplant chronic allograft dysfunction secondary noncompliance presented right chest skin lesion fever Initially suspected cutaneous tuberculosis malignancy investigations including skin biopsy revealed cutaneous leishmaniasis patient responded well treatment liposomal amphotericin B highlighting importance considering leishmaniasis differential diagnoses especially immunocompromised individual from travelling to endemic regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786644/",
        "source_type": "Global"
    },
    {
        "pmid": "40781989",
        "title": "Pediatric Cutaneous Leishmaniasis: A Case Series in a Montreal Tertiary Care Hospital.",
        "abstract": "diagnosis management cutaneous leishmaniasis CL pose important challenge pediatric population determined CL clinical characteristic infected child Montreal Canada Demographic clinical data medical record child CL retrieved retrospectively 20042023 SainteJustine University Medical Center Fourteen child 9 boy 5 girls CL first 9 second 5 generation immigrant immigrated travelled country origin CL developed post arrivalreturn Canada mean 66 months mean age onset 84 year range 316 years Lesions multiple 10 cases face leg frequently involved mean diagnostic delay 3 months largely due limited access healthcare initial misdiagnoses range 17 months Histopathology 12 polymerase chain reaction 8 7 confirmed diagnosis Two patient cleared CL without treatment 2 others showed clinical improvement antileishmanial agent treatment alone Patients treated fluconazole 7 liposomal amphotericin B 6 either alone association intralesional meglumine antimoniate 2 mean time CL onset resolution 5 month range 110 months resulting atrophic scar 10 patient known outcome Awareness occurrence CL child living nonendemic country result earlier diagnosis treatment better outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781989/",
        "source_type": "Global"
    },
    {
        "pmid": "40768926",
        "title": "Mechanistic, in-silico and in vitro studies with nitrofurans reveal potent leishmanicidal activity and inhibition of trypanothione reductase.",
        "abstract": "Visceral leishmaniasis caused Leishmania infantum Leishmania donovani one neglected tropical disease NTDs caused trypanosomatids treatment option limited outdated drug often causing adverse effect promoting drug resistance Previous antileishmanial drug discovery campaign identified nitroheterocyclic molecule high efficacy high selectivity index Therefore evaluated screening platform fluorescent L donovani amastigotes antileishmanial activity seven nitrofuran derivatives furazolidone nitrofurazone nitrofurantoin nifurtimox 5nitro2furaldehyde diacetate PYZD4409 5nitro2furonitrile compound showed good efficacy axenic intramacrophage amastigotes showing low cytotoxicity mammalian cell lines nitrofuran derivative induced reactive oxygen specie production axenic amastigotes inhibited trypanothione reductase TryR either uncompetitive competitive manner thus suggesting mechanism action involves increased oxidative stress caused imbalance redox metabolism Furazolidone exhibited promising antileishmanial profile molecular docking analysis revealed consistency strongest TryR uncompetitive inhibitory effect demonstrating high affinity alternative binding site near substrate oxidized trypanothione pocket Docking result also highlighted PYZD4409 compound highest binding affinity showed consistency competitive inhibition mechanism Furthermore similar binding mode identified across L donovani TryR homologous protein suggest potential broadspectrum activity nitrofuran derivatives thus underscoring importance promising candidate development novel antileishmanial therapy broadspectrum applications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768926/",
        "source_type": "Global"
    },
    {
        "pmid": "40764931",
        "title": "Systematic suppression of Leishmania (Leishmania) amazonensis-mediated delayed-type hypersensitivity response in American cutaneous leishmaniasis.",
        "abstract": "American cutaneous leishmaniasis ACL protozoan parasitic disease caused different Leishmania spp L Leishmania L Viannia subgenera Brazil seven Leishmania spp act ACL agents Infection L L amazonensis present wide clinicalimmunopathological spectrum ranging localized cutaneous leishmaniasis LCL usually responds well antimony therapy borderline disseminated cutaneous leishmaniasis BDCL may require twice much LCLantimony therapy cure and finally anergic diffuse cutaneous leishmaniasis ADCL highly resistant chemotherapy clinical variability driven different degree Tcell immunosuppression negatively impact delayedtype hypersensitivity DTH assessed Montenegro skin test MST Given MSTs role Tcellmediated resistance marker used diagnosing monitoring patient LCL n  8 BDCL n  3 due L L amazonensis assess Tcell immunosuppression patients MST assessed diagnosis treatment although one patient LCL refused treatment study took place Evandro Chagas Institute Pará Brazil diagnosis confirmed parasitological assays MST using L V braziliensis antigen indirect fluorescent antibody test IFATimmunoglobulin IgG serology histopathology PCR Phenotypic genotypic analysis used identify primary agent MST negative patients successful treatment Notably one patient LCL declined treatment also showed MST reactivity spontaneous healing absence MST reactivity persisted 1 year postcure LCL 2 year BDCL indicating sustained lack MST reactivity regardless treatment outcome spontaneous healing lack MST reactivity pre posttreatment LCL BDCL challenge role DTH marker Tcellmediated resistance L L amazonensis infection Moreover first case spontaneous LCL cure L L amazonensis showed MST reactivity pre postresolution raising doubt role DTH process",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Hypersensitivity, Delayed",
            "Female",
            "Male",
            "Adult",
            "Middle Aged",
            "Leishmania",
            "Skin Tests",
            "Antiprotozoal Agents",
            "Leishmania mexicana",
            "T-Lymphocytes",
            "Brazil",
            "Antimony"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764931/",
        "source_type": "Global"
    },
    {
        "pmid": "40755873",
        "title": "Efficacy and safety of microneedling with topical insulin compared with placebo in the treatment of atrophic scars: a prospective study and literature review.",
        "abstract": "Atrophic scars affect many individual arise various causes currently lack standardized treatment protocol Recent study suggest combining microneedling topical insulin TI may offer promising new approach improving appearance scars evaluate efficacy safety microneedling combined TI treating atrophic scar caused acne cutaneous leishmaniasis stria alba postoperative wounds Additionally aimed assess impact treatment improving quality life total 158 patient various type atrophic scar divided two groups one received microneedling TI received microneedling placebo participant underwent 12 monthly sessions followed 1year followup assess longterm outcomes Primary outcome measured via Goodman Baron qualitative grading system acne scarring grading system along patient satisfaction Dermatology Life Quality Index scores statistically significant improvement observed TI group reported patient clinicians especially regarding postacne postleishmaniasis scar iPi  0001 improvement quality life pronounced postacne group iPi  0002 study suggests microneedling combined TI safe effective standalone treatment atrophic scar resulting various causes Additionally approach may enhance quality life patient condition However research larger sample size needed validate findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755873/",
        "source_type": "Global"
    },
    {
        "pmid": "40753261",
        "title": "Establishment of THTT derivatives as potential antileishmanial and anti-inflammatory agents through in vitro and in silico investigations.",
        "abstract": "Cutaneous leishmaniasis neglected tropical disease NTD caused Leishmania tropica Leishmania major member species pose significant challenge public health sector especially developing countries limitation current treatments including toxicity resistance availability cost effectiveness necessitate development novel therapeutics study investigated leishmanicidal potential five Thiadiazine thione derivative THTT L tropica dose range 25426 µM using MTT assay Compounds T9 T24 T25 trisTHTT PG monoTHTT exhibited notable ICsub50sub value 2001 2694 2771 8279 µM respectively Moreover compound demonstrated promising docking score critical leishmanial enzymes Trypanothione reductase Trypanothione synthetase Leishmanolysin C24sterol methyl transferase Hemolytic assay revealed compound nontoxic lower concentrations MonoTHTTs PG BG showed higher CCsub50sub value ie 40165 37568 compared trisTHTTs T9 T24 T25 10461 10451 8973 µM respectively derivative showed high selectivity index SI compared standard drug AmphotericinB Furthermore insilico investigation targeting COX1 COX2 enzyme unveiled high affinity tested compound towards enzymes indicating potential involvement antiinflammatory agents Subsequent invitro HRBC membrane stabilization egg albumin denaturation assay confirmed antiinflammatory potential compounds finding validate THTT derivative effective novel class antileishmanial agent L tropica favorable safety profile potential antiinflammatory properties research recommended elucidate mechanism action invivo efficacy",
        "mesh_terms": [
            "Antiprotozoal Agents",
            "Anti-Inflammatory Agents",
            "Leishmania tropica",
            "Molecular Docking Simulation",
            "Animals",
            "Computer Simulation",
            "Humans",
            "Thiones",
            "Mice"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40753261/",
        "source_type": "Global"
    },
    {
        "pmid": "40752712",
        "title": "Polymeric micelles loaded with a 1,2,3-triazolium derivative: a promising strategy against tegumentary leishmaniasis.",
        "abstract": "Current drug used treat tegumentary leishmaniasis TL toxic present high cost andor emergence resistant strains Thus requirement identify new antileishmanial candidate and present study 123triazolium derivative called Nic incorporated polymeric micelle used treat Leishmania amazonensisinfected BALBc mice Animals infected and 60 day postinfection received saline empty micelle MIC Nic NicMIC amphotericin B AmpB drug control one 30 day therapy animal euthanized blood samples infected tissue organ collected perform biochemical parasitological immunological assays Results showed time points mouse treated NicMIC generated antileishmanial Th1type cellular humoral response characterized significantly higher level P  005 IFNγ IL12 IFNγ mRNA expression nitrite IgG2a antibodies Significant reduction parasite load found evaluating livers spleens draining lymph node infected footpad animals addition low level urea creatinine alanine transaminase aspartate transaminase found sera conclusion data suggest NicMIC could considered future study therapeutic candidate TL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40752712/",
        "source_type": "Global"
    },
    {
        "pmid": "40752711",
        "title": "Metal-organic frameworks (MOFs): Redefining antiparasitic drug delivery.",
        "abstract": "Metalorganic framework MOFs represent highly promising platform biomedical field particularly advanced drug delivery customizable design permit precise adjustment porosity pore size chemical composition render ideal vehicle efficient transport controlled release therapeutic agents capability crucial addressing parasitic diseases review focus use MOFs drug delivery system used parasitic diseases MOFs highly effective drug delivery systems capacity encapsulate precisely release antiparasitic compound enhances therapeutic potency enabling lower dos reduce toxicity improve patient safety eg Chagas disease Additionally MOFs augment drug activity bioavailability facilitating targeted delivery infection sites also protect vital tissue modulate hosts immune response Certain MOFs exhibit antiinflammatory antioxidant cytoprotective properties application demonstrated various parasitic diseases including cutaneous leishmaniasis Chagas disease chronic toxoplasmosis trichinosis challenge persist optimizing synthesis achieving precise controlled release ensuring longterm biocompatibility promising result obtained date unequivocally warrant sustained investment research development Ultimately MOFs could provide effective safer highly targeted treatments thereby transforming life million affected diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40752711/",
        "source_type": "Global"
    },
    {
        "pmid": "40751264",
        "title": "Seasonal variation of anti-Leishmania infantum antibodies and laboratory abnormalities in dogs with leishmaniosis.",
        "abstract": "dog affected leishmaniosis laboratory abnormality antiLeishmania antibody titer crucial initial relapse diagnosis well informing therapeutic decisions study aimed evaluate laboratory finding L infantum seropositive dog transmission season basis evidence antiL infantum antibody titer vary sand fly nonsand fly transmission period dog area leishmaniosis endemic September 2021 transmission season T1 January 2022 nontransmission season T2 L infantum seropositive dog physically examined blood sampling performed laboratory tests time points dog underwent routine hematology complete biochemical panel including acute phase protein ie Creactive protein CRP ferritin erythrocyte sedimentation rate ESR measurement serum capillary electrophoresis serology L infantum Potential coinfections arthropodborne Anaplasma phagocythophilum Ehrlichia canis Dirofilaria spp snailborne Angiostrongylus vasorum pathogen also excluded Total protein CRP level slightly reduced T2 compared T1 although difference statistically significant Antibody titer also decreased 10 18 dog 555 two 20 becoming seronegative remained constant eight 18 dog 444 Furthermore statistically significant reduction observed globulin percentage ferritin ESR whereas albumin percentage total iron level significantly increased AntiL infantum antibody titer laboratory abnormality seropositive dog living endemic area leishmaniosis may vary variation may related vector seasonality and consequently dogs exposure sand fly saliva potential reinfections result reinforce importance considering sampling season clinical evaluation management dog affected leishmaniosis avoid misdiagnosis unnecessary antileishmanial treatments",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Leishmania infantum",
            "Dog Diseases",
            "Seasons",
            "Antibodies, Protozoan",
            "Leishmaniasis, Visceral",
            "Male",
            "Psychodidae",
            "Female",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751264/",
        "source_type": "Global"
    },
    {
        "pmid": "40747852",
        "title": "Cutaneous Leishmaniasis Treatment and Care in Neglected Settings with Poor Access to Medicines.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747852/",
        "source_type": "Global"
    },
    {
        "pmid": "40747508",
        "title": "Seroprevalence of Canine Leishmaniasis in Sheltered Dogs in Bushehr Province, Southwest of Iran during 2022-2023.",
        "abstract": "Mediterranean form visceral leishmaniasis VL endemic region Iran often seen child 10 year old 90 mortality patients diagnosis treatment done time Canids reservoirs play important role spread disease Bushehr Province southern Iran always mentioned one endemic area VL purpose first study region 112 sheltered dog Bushehr City evaluated canine leishmaniasis CanL using serological Direct Agglutination Test DAT well detailed clinical examinations 112 sample collected 714 case antiiL infantumi IgG antibody titer 180 higher therefore considered seropositive Furthermore 70 seropositive dog antibody titer 1320 higher 47 42 least one clinical symptom associated VL considered case CanL current seroprevalence situation dog region noticeable important alarm policymakers health system practitioners comprehensive complementary parasitological study carried number reservoir region diagnosis treatment accurately determine statistic disease compared obtained seroprevalence status",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747508/",
        "source_type": "Global"
    },
    {
        "pmid": "40747503",
        "title": "Spatial Epidemiology of Clinical Forms of Cutaneous Leishmaniasis and Treatment Practice: Evidence from Leishmaniasis Research and Treatment Center, Northwest Ethiopia.",
        "abstract": "aimed conduct comprehensive analysis cutaneous leishmaniasiss CL clinical polymorphism examining relationship clinical forms duration illness spatiotemporal distribution retrospective study University Gondar Hospital analyzed cutaneous leishmaniasis patient treated 2022 2024 Demographic epidemiologic data collected parasite detection via microscopic clinical examination Overall 454 CL case 49 district diagnosed predominantly affecting male aged ≤30 mean age 2531 yr SD ±183 Significant difference noted age sex iPi005 Approximately 70 lesion ≥4 cm CL case 2 parasite loads Sodium stibogluconate SSG remained primary treatment choice patients spatial distribution CL case covered larger geographical area although case 20 concentrated Central Gondar mucosal CL shared similar geographical pattern recurrent CL type Notably 48 chronic presentation lived disease ≥12 months diffuse CL DCL longer delay seen clinical presentation associated longitudinal time series Acute patient exhibited higher parasitic load chronic one 38 vs 24 respectively CL significantly affected schoolaged children symmetrical distribution case district studied could increase attention clinician enhance management strategies Extended disease duration necessitated specialized treatment clinical transitions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747503/",
        "source_type": "Global"
    },
    {
        "pmid": "40747498",
        "title": "Evaluating the Effects of Imiquimod on Paths of TLRs and Inflammatory Cytokines Signaling in Infected Macrophages with <i>Leishmania major</i> in Vitro and in Vivo.",
        "abstract": "iLeishmania majori obligate intracellular pathogen macrophage cell host iL majori Imiquimod stimulates macrophage secrete different cytokine via expression TLRs study carried Department Parasitology Faculty Medical Sciences Tarbiat Modares University 2018 effect imiquimod investigated noninfected infected macrophage iL majori expression Tolllike receptor TLRs inflammatory cytokines TLRs play important role enhancing proceeding phagocytosis killing parasites Moreover cytokine TNFα IL6 IL1 often identified inflammatory condition interfering target treatment Healthy macrophage macrophage infected iLeishmania majori parasite affected different concentration imiquimod expression TLR gene TLR1 TLR2 TLR3 TLR4 TLR7 TLR9 cytokine evaluated real time RTPCR experiment laboratory animals infected BALBc mouse exposed imiquimod isolated peritoneal macrophages expression TLR2 decreased noninfected macrophage affected imiquimod expression level TLR7 healthy macrophages decreased difference control group significant Imiquimod increase expression inflammatory cytokine IL12 mouse macrophage also decrease expression IL10 suggests imiquimod may improve therapeutic effect infected mouse iLeishmania majori Imiquimod cause TLR2 decreased expression TLR7 TLR9 increased expression Imiquimod TLR7 agonist enhance recovery leishmaniasis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747498/",
        "source_type": "Global"
    },
    {
        "pmid": "40745935",
        "title": "Oral Treatment With Heat Shock Protein 65-Producing Lactococcus lactis Induces Regulatory T Cells, Modulating Inflammatory Response in Leishmania braziliensis Infection.",
        "abstract": "Cutaneous leishmaniasis CL neglected tropical disease prevalent Brazil caused Leishmania braziliensis L braziliensis marked ulcerative skin lesion exacerbated Th1driven inflammatory response study investigates therapeutic potential oral tolerance OT induced genetically modified strain Lactococcus lactis L lactis producing heat shock protein 65 HSP65 Mycobacterium leprae murine model CL BALBc mouse infected L braziliensis treated orally HSP65producing L lactis control L lactis empty vector four consecutive days starting 4 week postinfection Mice receiving HSP65producing L lactis showed reduced lesion size parasite burden Cytokine analysis draining lymph node revealed shift proinflammatory IFNγ response increased IL10 production correlating milder inflammation less tissue damage Additionally treatment promoted increase regulatory cell Tregs including CD4supsupCD25supsupFOXP3supsup CD4supsupLAPsupsup membraneassociated TGFβ cell draining lymph nodes therapeutic effect observed severe model CL using Leishmania major study underscore potential oral tolerance induction using HSP65producing L lactis promising immunoregulatory therapeutic approach chronic inflammatory infections mainly display primed balance immune response",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745935/",
        "source_type": "Global"
    },
    {
        "pmid": "40739813",
        "title": "Localized Cutaneous Nodule in an Elderly Patient.",
        "abstract": "Localized cutaneous nodule common elderly may indicate benign malignant conditions case highlight diagnostic challenge cutaneous leishmaniasis CL mimicked malignancy elderly woman minimal travel history CL due L donovani rare Europe confirmed via histopathology staining Given patients renal comorbidities prior cancer local treatment preferred systemic therapy CL included differential diagnosis chronic nodules especially patient past travel endemic areas Biopsy remains crucial accurate diagnosis appropriate individualized management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40739813/",
        "source_type": "Global"
    },
    {
        "pmid": "40737310",
        "title": "LeishTec vaccination disrupts vertical transmission of Leishmania infantum.",
        "abstract": "Zoonotic canine leishmaniosis caused Leishmania infantum fatal disease worldwide human reservoir host dogs primary route transmission via sand fly bite Vertical transplacental transmission L infantum offspring shown critical maintenance infection endemic nonendemic areas United States canine leishmaniosis CanL enzootic within hunting dog populations Previous work US hunting dog found transplacental transmission L infantum occurs frequently high infectivity Dogs born CanL infected mother almost fourteen time likely become positive L infantum lifetime Globally public health agency control CanL canine human case detection treatment case dog culling reducing vector populations specific strategy control vertical transmission CanL previous randomized field trial US hunting dog found Leishmania A2 protein saponinadjuvanted vaccine LeishTec used immunotherapy significantly reduced risk progression clinically overt leishmaniasis 30 asymptomatic dogs unknown whether maternal vaccination could inhibit infection risk offspring hypothesized dog born infected vaccinated dam would less likely test diagnostically positive via L infantum specific kqPCR serology compared dog born infected unvaccinated mothers population dog born L infantum infected dam evaluated assess LeishTec vaccination prevent transmission offspring Dogs born unvaccinated L infantum infected dam higher mortality 1250 v 000 higher likelihood clinical disease 9412 v 5900 likely diagnostically positive CanL 2222 v 455 Vaccination dam already infected prior pregnancy greatly reduced risk transplacental transmission L infantum Incorporating vertical transmission prevention public health intervention country Leishmania endemic could aid infection control",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Leishmania infantum",
            "Infectious Disease Transmission, Vertical",
            "Dog Diseases",
            "Leishmaniasis, Visceral",
            "Female",
            "Vaccination",
            "Leishmaniasis Vaccines",
            "Pregnancy",
            "Humans"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40737310/",
        "source_type": "Global"
    },
    {
        "pmid": "40732717",
        "title": "Investigation of <i>Leishmania infantum</i> Infection and Feeding Preferences of <i>Lutzomyia longipalpis</i> During Deltamethrin (4%) Dog Collar Intervention.",
        "abstract": "Leishmaniasis zoonotic disease caused protozoa genus iLeishmaniai transmitted phlebotomine sand flies Understanding feeding behavior infection rate vector crucial disease surveillance control aimed investigate natural infection rate iLeishmaniai spp phlebotomines analyze bloodfeeding pattern one priority area state São Paulo implementation insecticideimpregnated dog collars Sand fly collected urban periurban area 2022 2024 using CDC light traps manual aspiration Shannon traps PCR used detect iLeishmaniai DNA SSU rDNA gene blood meal source COI gene total 414 sand fly collected 222 engorged female analyzed blood meal 192 specimen tested iLeishmaniai spp infection predominant blood source human 67 followed chicken 641 dog 189 considering 451 sample presented mixed blood meals iLeishmania infantumi found 1 samples finding highlight feeding plasticity sand fly potential role disease transmission reinforcing need continuous epidemiological surveillance vector control strategies particularly implementation insecticideimpregnated dog collars",
        "mesh_terms": [
            "Animals",
            "Psychodidae",
            "Leishmania infantum",
            "Dogs",
            "Pyrethrins",
            "Feeding Behavior",
            "Female",
            "Leishmaniasis, Visceral",
            "Insect Vectors",
            "Nitriles",
            "Insecticides",
            "Humans",
            "Brazil",
            "Dog Diseases",
            "Chickens"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40732717/",
        "source_type": "Global"
    },
    {
        "pmid": "40732071",
        "title": "Design, Synthesis, and Biological Evaluation of <i>N</i>-Acylhydrazones and Their Activity Against <i>Leishmania amazonensis</i> Promastigotes.",
        "abstract": "Leishmaniasis significant public health concern affecting million causing substantial mortality thus urgently requiring effective safer treatments study explored potential 33 novel iNiacylhydrazonederived compound iLeishmania amazonensisi parasites focusing inhibition iLeishmaniai arginase enzyme promastigote growth Compounds b8b b18b showed 90 inhibitory activity promastigote culture 72 h treatment Compound b8b showed ICsub50sub 105 µM 94118 µM compound b18b exhibited ICsub50sub 428 µM 413444 µM antipromastigote effect compound highlight potential new drug design finding offer promising starting point addressing pressing need new therapeutic option leishmaniasis addition used webbased tool predict compounds toxicity pharmacokinetic parameters Despite lack inhibition iL amazonensisi arginase enzyme investigation mechanism action compound vivo efficacy could contribute development safer effective treatment neglected tropical disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40732071/",
        "source_type": "Global"
    },
    {
        "pmid": "40730118",
        "title": "Exploring the phytomedicine properties of azadiradione against leishmaniasis: in silico and in vitro insights.",
        "abstract": "Leishmaniasis continues pose significant global health challenge exacerbated increasing resistance current therapeutic agent miltefosine amphotericin B growing resistance highlight urgent need alternative treatment strategies context phytomedicine emerged promising avenue novel antileishmanial therapies previous study crude extract derived neem Azadirachta indica leaf exhibited notable antileishmanial activity Subsequent analysis using LCMSMS enabled identification bioactive constituent within active fraction including azadiradione AZD drug potential therapeutic effect unexplored leishmaniasis AZD exhibited dosedependent growth inhibition along structural disruption DNA fragmentation promastigotes ICsub50sub 1709 μM silico docking simulation AZD identified Leishmania peroxidase eg ascorbate peroxidase tryparedoxin peroxidase probable molecular targets subsequent downregulation expression confirmed vitro CCsub50sub human macrophage MФs ECsub50sub intracellular amastigotes determined 5632 μM 1167 μM AZD respectively dosedependent reduction MФs infectivity demonstrates drug potential AZD pathogenic stage Leishmania However selectivity index SI AZD calculated 483 indicating moderate Leishmaniaspecific drug potential AZD decrease IL10 IL1β arginase expression increase IL12 iNOS expression reinforce immunoregulatory potential AZD favour host investigation required optimize dosage improve selectivity AZD proposing treatment Leishmania infection study demonstrated novel finding related drug potential AZD defined Leishmania target host protective cytokine response Studies animal model may deliver insight therapeutic potential",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40730118/",
        "source_type": "Global"
    },
    {
        "pmid": "40726640",
        "title": "Atypical presentations of cutaneous leishmaniasis in Morocco: Emerging clinical and epidemiological trends.",
        "abstract": "Cutaneous leishmaniasis CL endemic parasitic disease Morocco exhibit increasing diversity clinical manifestations clinical polymorphism often lead misdiagnosis delay treatment aim study illustrate atypical presentation CL series six case diagnosed department highlighting diagnostic challenge public health implications report six atypical case CL Case 1 33yearold male ulcerative crusty lesion lower lip mucosa mimicking epidermoid carcinoma Case 2 44yearold male chondritislike erythematosquamous plaque left ear Case 3 25yearold male welllimited erosive plaque right arm developed leishmaniasis recidivans Case 4 53yearold female ulceroverrucous facial lesion concomitant cutaneous lupus Case 5 69yearold female sarcoidosislike papulonodular facial lesion infiltrated nasal plaque mimicking lupus pernio Case 6 75yearold female crateriform lesion nose suggestive keratoacanthoma case illustrate changing clinical epidemiological profile CL Morocco highlighting importance early recognition precise diagnosis detailed anamnesis parasitological examinations underline necessity enhanced epidemiological surveillance awarenessraising among practitioner improve management control disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40726640/",
        "source_type": "Global"
    },
    {
        "pmid": "40722720",
        "title": "Sialic Acid and Colchicine Functionalized Silica Nanoparticles: A Novel Approach to Leishmanicidal Selective Treatments.",
        "abstract": "bBackgroundObjectivesb Leishmaniasis remains neglected tropical disease nearly one million new case annually limited investment research Current treatments primarily based pentavalent antimonials associated severe side effect increasing resistance study aim develop novel therapeutic strategy using nanomaterial functionalized sialic acid SA colchicine COL selectively target iLeishmania braziliensisi parasites bMethodsb nanostructured system engineered functionalizing surface SA COL SA chosen mimic host cell surfaces enhancing parasite attraction COL selected known leishmanicidal properties nanomaterial designed concentrate extracellular parasite surface via SAmediated interactions thereby increasing local COL efficacy bResultsb functionalized nanomaterial demonstrated dual mechanism SA facilitated selective accumulation iLeishmania braziliensisi parasite nanostructure surface COL exerted cytotoxic effect synergistic interaction resulted enhanced parasite mortality vitro suggesting improved selectivity potency compared conventional treatments bConclusionsb proposed nanomaterial offer promising alternative leishmaniasis treatment combining targeted parasite attraction localized drug delivery strategy may reduce systemic toxicity improve therapeutic outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40722720/",
        "source_type": "Global"
    },
    {
        "pmid": "40722705",
        "title": "Persistence of <i>L. V. braziliensis</i> in the Nasal Mucosa of Treated Patients.",
        "abstract": "bBackgroundObjectivesb Cutaneous leishmaniasis infectious disease frequently affect neglected populations Besides incidence high disease burden associated possibility mucosal sequelae Clinical followup patient difficult due limited access affected population healthcare long lapse development cutaneous mucosal diseases study evaluated positivity iL V braziliensisi DNA nasal mucosa patient treated leishmaniasis attempt estimate possible longterm risk developing mucosal leishmaniasis association important clinical characteristics bMethodsb Samples collected immediately treatment completion using nasal swab specific DNA amplified detected using realtime PCR Clinical laboratorial data systematically collected bResultsb positivity iL V braziliensisi 7 treatment 60 mucosal lesion treatment compared 134 patient negative iL V braziliensisi treatment ipi  0031 bConclusionsb Molecular detection iL V braziliensisi DNA nasal mucosa promising strategy improve followup treatment patient American Tegumentary Leishmaniasis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40722705/",
        "source_type": "Global"
    },
    {
        "pmid": "40717070",
        "title": "Nicolau syndrome in a pediatric patient after corticosteroid injection: a case report and review of the literature.",
        "abstract": "Nicolau syndrome rare serious complication occur following various form drug administration particularly intramuscular injections characterized onset painful edema affected area shortly injection often accompanied notable livedoid discoloration skin lead ischemic necrosis surrounding skin soft tissue muscular tissue Here report 4yearold Iranian girl developed significant swelling discoloration buttock area accompanied severe pain receiving intramuscular injection triamcinolone acetonide progressive vitiligo basis patients clinical presentation medical history imaging findings definitive diagnosis NS established managed effectively prophylactic antibiotics analgesics antithrombotic therapy Healthcare provider must aware potential complication associated intramuscular injections Recognizing sign distress significant pain discoloration crucial timely intervention significantly improve patient outcomes",
        "mesh_terms": [
            "Humans",
            "Female",
            "Injections, Intramuscular",
            "Nicolau Syndrome",
            "Child, Preschool",
            "Triamcinolone Acetonide",
            "Glucocorticoids",
            "Buttocks",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40717070/",
        "source_type": "Global"
    },
    {
        "pmid": "40720469",
        "title": "Application of the SARIMA-LSTM model to evaluate the effectiveness of interventions for Visceral Leishmaniasis.",
        "abstract": "study proposes combined Seasonal Autoregressive Integrated Moving Average Long ShortTerm Memory SARIMALSTM model enhance accuracy evaluating effectiveness visceral leishmaniasis prevention control effort Yangquan China Data obtained Yangquan Centre Disease Control Prevention hybrid model integrates SARIMA component residualbased LSTM neural network SARIMALSTM model LSTM component included seven hidden layer nodes learning rate 0001 500 training epochs batch size 256 utilized Adam optimization algorithm SARIMALSTM model demonstrated superior performance MSE  2824 MAE  1279 RMSE  1681 paired sample ttest revealed statistically significant difference predicted actual case count t  4058 p  0001 indicating actual number case lower predicted combined SARIMALSTM model outperformed individual SARIMA LSTM models suggesting implemented intervention generally effective",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Humans",
            "China",
            "Neural Networks, Computer",
            "Seasons",
            "Models, Statistical"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40720469/",
        "source_type": "Global"
    },
    {
        "pmid": "40712662",
        "title": "A Rare Periorbital Ulceronecrotic Wound: A Case of Anthrax Cellulitis.",
        "abstract": "Cutaneous anthrax zoonotic bacterial infection mostly involves head neck upper extremities Periorbital involvement cutaneous anthrax rare presentation lead severe irreversible complications Herein describe 25yearold girl periorbital anthrax cellulitis presented severe swelling right side face ulceronecrotic lesion right eyebrow receiving appropriate antibiotic regimen condition improved discharged without intraocular complications",
        "mesh_terms": [
            "Humans",
            "Female",
            "Anthrax",
            "Child, Preschool",
            "Anti-Bacterial Agents",
            "Skin Diseases, Bacterial",
            "Cellulitis",
            "Necrosis",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40712662/",
        "source_type": "Global"
    },
    {
        "pmid": "40709372",
        "title": "Unveiling potent anti-leishmanial agents: a QSAR exploration of diverse chemical scaffolds targeting <i>Leishmania donovani</i> amastigotes.",
        "abstract": "Leishmaniasis caused iLeishmaniai spp remains major global health concern due drug resistance toxicity nonspecificity prolonged treatments Addressing need new therapeutics investigated range bioactive compounds including chalcones pyrimidines quinolines azoles sulphonamides flavonoids quinazoline derivatives targeting iLeishmania donovanii amastigotes Key molecular descriptor influencing antileishmanial activity identified using LASSO multiple linear regression MLR yielding robust QSAR model irisup2sup  084 validated rigorous statistical analysis Virtual screening scaffoldhopping strategy led design 12 novel compounds among six mainly benzothiazole benzoxazole derivative exhibited clear predicted pIC₅₀ value promising ADMET profiles Quinolinebased compound showed moderate activity consistent prior experimental data Structural analysis revealed significance quinoline ring linked thiazole benzoxazole moieties modification like alkyl halide methyl group enhancing bioactivity molecular docking iLeishmania donovanii Nmyristoyltransferase LdNMT sterol 14α demethylase CYP51 demonstrated strong binding affinity compound N8 N9 N11 Structurebased similarity search using ChEMBL confirmed selective bioactivity low predicted cytotoxicity supporting minimal offtarget interactions finding present computationally guided framework developing effective targeted antileishmanial agents",
        "mesh_terms": [
            "Leishmania donovani",
            "Quantitative Structure-Activity Relationship",
            "Antiprotozoal Agents",
            "Molecular Docking Simulation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40709372/",
        "source_type": "Global"
    },
    {
        "pmid": "40708344",
        "title": "Geospatial technologies for targeting priority areas on surveillance and response of visceral leishmaniasis in São Paulo state, Brazil: embracing a One Health integrative approach.",
        "abstract": "2023 Brazil accounted 935 reported case visceral leishmaniasis VL Latin America study employing One Health approach aims i analyse spatial distribution VL using integrated geospatial methods ii temporal trend VL assess impact COVID19 pandemic occurrence cases iii identify spatial cluster municipality heightened environmental vulnerability prioritise surveillance control effort VL São Paulo state Brazil Archival database 1999 2022 analysed Highrisk cluster human VL HVL identified using Local Moran Index Incidence mortality rate modelled Generalized Additive Model Data distribution Lutzomyia longipalpis vector obtained São Paulos Supervision Control Endemics spatial distribution canine visceral leishmaniasis CVL based survey data Adolfo Lutz Institute Environmental factors including normalized difference vegetation index NDVI land surface temperature LST geomorphology derived Moderate Resolution Imaging Spectroradiometer MODIS data Environmental Information Database BDiA platform Lutzomyia longipalpis detected 324 municipalities CVL 290 HVL 180 western region characterised plateau geomorphology elevated deforestation higher temperatures accounted 306 highrisk clusters underscoring priority status control surveillance VL case remain stable COVID19 pandemic lethality rate increased Addressing VL reducing lethality rate pose significant challenge public health authority São Paulo coming years",
        "mesh_terms": [
            "Brazil",
            "Leishmaniasis, Visceral",
            "Humans",
            "Animals",
            "COVID-19",
            "Psychodidae",
            "One Health",
            "Dogs",
            "Dog Diseases",
            "Spatial Analysis",
            "Insect Vectors",
            "Incidence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40708344/",
        "source_type": "Global"
    },
    {
        "pmid": "40700721",
        "title": "Optic Neuritis Associated with Herpes Zoster Ophthalmicus: A Systematic Review and Analysis.",
        "abstract": "systematically review analyze reported case herpes zoster ophthalmicus HZOrelated optic neuritis ON without retinal involvement potentially sightthreatening complication varicellazoster virus VZV PRISMAguided search online database inception January 31 2025 identified case report series describing HZOrelated without retinal involvement Study quality assessed using Joanna Briggs Institute checklists Data demographics clinical features diagnostics treatments outcome analyzed using SPSS Thirtytwo study 19192025 comprising 38 patient included mean patient age 526 year ranging 6 82 nearequal gender distribution Comorbid condition human immunodeficiency virus HIV infection diabetes autoimmune disorder noted onethird cases commonly presented unilaterally ipsilateral dermatome HZO mean interval HZO onset approximately 22 day ranging 10 day prior 150 day afterward Blurred vision eye pain frequent symptoms Common sign include visual field defect congestion mydriasis ophthalmoplegia Keratitis common observation slitlamp examination 628 22 35 cases Corticosteroid therapy including highdose pulse regimens administered thirdfourth 28 38 patients outcome assessment 528 19 36 achieved mild impairment 363 12 36 experienced clinical blindness HZOrelated uncommon significant sightthreatening complication HZO Timely diagnosis appropriate antiviral treatment along corticosteroid therapy may improve visual prognosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40700721/",
        "source_type": "Global"
    },
    {
        "pmid": "40694583",
        "title": "Outbreak of cutaneous leishmaniasis amongst militia members in a non-endemic district under conflict in the lowlands of Somali Region caused by Leishmania tropica, Eastern Ethiopia.",
        "abstract": "Cutaneous leishmaniasis CL Ethiopia typically linked highaltitude region recently emerged unusually low altitude 500 meter Somali Region raising public health concerns Cutaneous leishmaniasis previously identified region conflict starting area militia infected serious lesions Routine clinical sociodemographic information extracted patient chart using case report form Additionally clinical laboratory data obtained 30 patient suspected CL Skin scraping fine needle aspirate collected raised edges nodular centre lesion followed DNA extraction using DNeasy Blood Tissue kit total 1050 CL patient recruited male militia members immunologically naïve displaced conflict area likely sylvatic transmission cycle identified Leishmania tropica causative species challenging previous assumption L aethiopica primary agent CL Ethiopia Notably 77 patient 10 lesions presentation atypical L tropica elsewhere Phlebotomus orientalis P sergenti vector visceral leishmaniasis CL North Africa respectively found outbreak area research needed explore ecoepidemiology outbreak patients treatment responses Insights help develop management strategy control newly emerging form CL prevent spread region hybridization Leishmania strain causing VL endemic area",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Ethiopia",
            "Male",
            "Leishmania tropica",
            "Disease Outbreaks",
            "Adult",
            "Middle Aged",
            "Young Adult",
            "Adolescent",
            "Child",
            "Female",
            "Somalia",
            "Aged",
            "Animals",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40694583/",
        "source_type": "Global"
    },
    {
        "pmid": "40689741",
        "title": "Exploring the <i>in vitro</i> and <i>in vivo</i> antileishmanial potential of Marizomib against <i>Leishmania amazonensis</i> and <i>Leishmania infantum</i>.",
        "abstract": "Current treatment available leishmaniasis fraught numerous problems search new treatment alternative leishmaniasis urgent necessary proteasome selected promising target Marizomib proteasome inhibitor shown antitumor effects ongoing clinical tests work aimed evaluate iin vitroi iin vivoi effect Marizomib iLeishmania amazonensisi iLeishmania infantumi Interestingly Marizomib effective promastigote form iL amazonensisi iL infantum vitroi showed significant effect intracellular amastigotes iL amazonensisi iL infantumi showing selectivity parasite compared host cell Furthermore transmission electron microscopy possible show Marizomib induces extensive ultrastructural change amastigotes iL amazonensisi iL infantumi appearance many vacuole parasite cytoplasm mitochondrial swelling Marizomib also shown effective murine model cutaneous leishmaniasis reduction size lesion parasite load footpad draining lymph node animal infected iL amazonensisi also effective model visceral leishmaniasis reduction parasite load spleen liver animal infected iL infantumi Importantly Marizomib treatment regimen used cause renal hepatic acute toxicity infected animals result highlight antileishmanial potential Marizomib encouraging u conduct preclinical test animal models well clinical trials",
        "mesh_terms": [
            "Animals",
            "Leishmania infantum",
            "Antiprotozoal Agents",
            "Mice",
            "Leishmaniasis, Visceral",
            "Leishmania mexicana",
            "Mice, Inbred BALB C",
            "Leishmaniasis, Cutaneous",
            "Female",
            "Microscopy, Electron, Transmission"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40689741/",
        "source_type": "Global"
    },
    {
        "pmid": "40686227",
        "title": "Synergistic Effect of Copper Nanoparticles and Paromomycin in the Treatment of Cutaneous Leishmaniasis.",
        "abstract": "interest nanotechnology application medicine particularly combating microbial infections surged recent years study investigated vitro vivo antileishmanial effect copper nanoparticles CuNPs green synthesised using Capparis spinosa fruit extract conjunction paromomycin PM CuNPs synthesised methanolic extract C spinosa assessed vitro antileishmanial activity CuNPs 10200 μgmL well concentration CuNPs 10200 μgmL combined PM 10200 μgmL targeting promastigote amastigote form Leishmania major Additionally evaluated cytotoxic effect CuNPs THP1 cells Subsequently tested formulation female BALBc mouse infected L major study measured footpad swelling quantified parasite load realtime PCR assessed level cytokine interleukin4 IL4 gamma interferon IFNɤ nitric oxide NO arginase ARG result demonstrated CuNPs particularly combined PM significantly inhibited p  0001 growth L major promastigotes amastigotes stimulated IFNɤ production reduced IL4 ARG level p  005 Importantly CuNPs exhibited minimal cytotoxicity towards THP1 cells infected mice treatment CuNPs notably combination PM resulted significant p  005 reduction mean number parasites Treatment CuNPs concentration 100 200 mgmL led decrease lesion diameter result study highlight potent antileishmanial activity synergistic effect CuNPs alone combination PM L major promastigotes amastigote forms well potential treating cutaneous leishmaniasis CL BALBc mice",
        "mesh_terms": [
            "Animals",
            "Paromomycin",
            "Copper",
            "Leishmaniasis, Cutaneous",
            "Mice, Inbred BALB C",
            "Female",
            "Metal Nanoparticles",
            "Leishmania major",
            "Antiprotozoal Agents",
            "Humans",
            "Mice",
            "Drug Synergism",
            "THP-1 Cells",
            "Plant Extracts",
            "Parasite Load",
            "Disease Models, Animal",
            "Cytokines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40686227/",
        "source_type": "Global"
    },
    {
        "pmid": "40685763",
        "title": "Combating Drug-Resistant Protozoal Infections: A Review of Emerging Therapeutics.",
        "abstract": "Protozoal infection remain significant global health burden despite significant progress understanding infection recent year due continuing emergence multidrug resistance among protozoal parasites review focus recent innovation protozoal disease treatment aimed combating growing challenge drug resistance escalating prevalence multidrug resistance among protozoal parasites especially responsible widespread disease malaria leishmaniasis trypanosomiasis rapidly emerging grave threat human health worldwide resistance undermines efficacy existing treatments making imperative develop explore novel therapeutic approaches Diverse strategies including concept hybrid drugs development advanced analog existing drugs drug repurposing employed counter drug resistance outmaneuvering evolution resistant parasite restoring effectiveness treatments review delve significant finding reported 2020 2024 aim providing overview state protozoal disease treatment highlighting progress made exploring promising avenue tackling devastating diseases offering insight future direction overcoming persistent challenge drug resistance Given emergence drug resistance call multifaceted approach address protozoal infections longterm success depends interdisciplinary research collaborations equitable access treatment appropriate drug resistance surveillance addition advancement research development therapeutic strategy described review",
        "mesh_terms": [
            "Humans",
            "Antiprotozoal Agents",
            "Protozoan Infections",
            "Animals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40685763/",
        "source_type": "Global"
    },
    {
        "pmid": "40677299",
        "title": "A Case Report of Venous Ulcer Mimicking Cutaneous Leishmaniasis.",
        "abstract": "Venous ulcer sometimes difficult diagnose accurately resemble skin lesion cutaneous leishmaniasis Here present patient venous ulcer mimic cutaneous leishmaniasis mycetoma lesions 50yearold female patient presented nonhealing venous ulcer right lower leg suspected cutaneous leishmaniasis ulcerated mycetoma lesions misdiagnosed cutaneous leishmaniasis referred Rufaa teaching hospital AlGezira State Sudan color Doppler sonography result revealed several finding consistent chronic venous insufficiency including incompetent superficial femoral junction SFJ short reflux among great saphenous vein GSV incompetent saphenopopliteal junction SPJ short reflux along small saphenous vein SSV Additionally examination showed patency compressibility GSV SSV well presence superficial varicose veins Surgical closure fistula done case report highlight challenge distinguishing venous ulcer mycetoma cutaneous leishmaniasis current case emphasizes importance considering comprehensive assessment patients medical history physical examination potentially diagnostic tests Collaborating experienced healthcare providers dermatologist wound care specialists may also beneficial confirming diagnosis developing appropriate treatment plan",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40677299/",
        "source_type": "Global"
    },
    {
        "pmid": "40670989",
        "title": "Prunus amygdalus var. amara seed extract enhances the antileishmanial activity of miltefosine.",
        "abstract": "Leishmaniasis infectious disease transmitted via sand fly caused protozoan parasite Leishmania spp treatment disease quite challenging due high cost resistance toxicity conventional drugs Various research study demonstrated plant based drug possess least toxicity antiinflammatory antioxidant properties Here evaluation antileishmanial activity methanolic Prunus amygdalus var amara seed extract conducted found inhibited L donovani proliferation cause apoptosis Moreover combination miltefosine enhanced antileishmanial effects GCMS analysis confirmed presence various phytochemical extract contributed pharmacological efficacy finding highlighted potential herbal product valuable source new treatment leishmaniasis antileishmanial effect determined promastigote amastigote assays Parasite load evaluated staining L donovaniinfected macrophage modified Giemsa stain Cytotoxicity seed extract estimated MTT 34 5 dimethylthiazol2yl2 5diphenyl tetrazolium bromide assay addition Proapoptotic event inferred using RTPCR qRTPCR characterization phytoconstituents evaluated gas chromatography mass spectrometry extract promoted dosedependent reduction growth promastigotes IC50  4312 ± 303 μgml amastigotes IC50  4965 ± 334 μgml Further extract combination miltefosine showed enhanced antileishmanial activity form L donovani promastigotes IC50  4547 ± 12 μgml well amastigotes IC50  1954 ± 24 μgml Earlystage apoptotic event also observed promastigote form determining increased expression LdMetacaspase PARP1 cytotoxic potential THP1 differentiated macrophage assessed indicated insignificant cytotoxicity different dos extract CC50  79919 ± 13459 μgml combination miltefosine CC50  38416 ± 17747 μgml Furthermore presence phytocompounds like chaulmoogric acid hydnocarpic acid described first time Prunus amygdalus var amara seed extract finding indicated EPA play significant role combating leishmaniasis hold promise potential treatment disease Moreover combined miltefosine EPA demonstrated increased effectiveness leishmaniasis Therefore combination EPA miltefosine present promising outlook potential therapy leishmaniasis",
        "mesh_terms": [
            "Plant Extracts",
            "Phosphorylcholine",
            "Antiprotozoal Agents",
            "Seeds",
            "Animals",
            "Leishmania donovani",
            "Apoptosis",
            "Mice",
            "Humans"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40670989/",
        "source_type": "Global"
    },
    {
        "pmid": "40670370",
        "title": "IL-12 mRNA-LNP promotes dermal resident memory CD4<sup>+</sup> T cell development.",
        "abstract": "Dermal resident memory CD4supsup cell dTrm provide protection vectorborne infections However factor promote development remain unclear tested mRNA vaccine encoding protective leishmanial antigen induced dTrm cells mRNA vaccine induced robust systemic Tcell responses Trm cell found skin Since IL12 promotes Th1 responses tested whether IL12 mRNA combined mRNA vaccine could enhance dTrm cell development combination significantly expanded Leishmaniaspecific Th1 cell expressing skinhoming molecule memory cell marker draining lymph node Additionally higher number dTrm cell maintained skin mouse exhibited functional immunity indicated delayed hypersensitivity response protection upon challenge Leishmania finding highlight IL12 key driver CD4supsup dTrm development enabling global seeding across skin underscore potential IL12enhanced mRNA vaccine generate durable immunity cutaneous leishmaniasis skintargeted infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40670370/",
        "source_type": "Global"
    },
    {
        "pmid": "40666521",
        "title": "The F1F3 recombinant chimera induced higher vaccine efficacy than its independent F1 and F3 components against <i>Leishmania</i> (<i>L.</i>) <i>infantum chagasi</i> mice infection.",
        "abstract": "Visceral leishmaniasis VL severe human vectorborne CD4immunosuppressive disease lethal untreated soon symptom arise vaccine available human VL chemotherapy highly toxic requires hospitalization VL patient show substantially decreased CD4subsub total iLeishmaniaispecific CD4 cell counts iLeishmania L donovanii nucleoside hydrolase NH36 DNA metabolism enzyme conserved marker iLeishmaniai genus considered among iLeishmaniai antigens vaccine candidate mouse vaccinated NH36 protection VL mediated CD4subsub cell response NH36 Cterminal domain F3 cutaneous leishmaniasis CL CD4 response F3 CD8 response NH36 Nterminal F1 Vaccination recombinant chimera containing F1 F3 domain expressed tandem F1F3 protected mouse heterologous CL infection iL L amazonensisi iL V braziliensisi investigation BALBc mouse immunized either F1 F3 mixture both F1F3 chimera plus saponin challenged amastigotes iL L infantum chagasii agent VL America infection F1F3 chimera F3 vaccine promoted highest IgA IgM IgG IgG1 IgG2a IgG2b IgG3 antibody responses F1F3 chimera promoted strongest intradermal response leishmanial antigen highest body weight gain potent reduction spleen liver relative weights addition F1F3 chimera vaccine increased secretion IFNγ and together F3 vaccine secretion TNFα splenocytes F1F3 chimera F1 vaccine also promoted strongest secretion IL10 low mouse immunized F3 Thus IFNγIL10 TNFαIL10 ratios characteristic Th1 response increased mouse vaccinated F3 F1F3 chimera F3 vaccine reduced parasite load liver F1F3 chimera described heterologous CL infections also optimizes protection homologous visceral leishmaniasis infection iL L infantum chagasii Th1 contribution F3 peptide regulatory response F1 peptide Expression F1 F3 domain iin tandemi induced higher efficacy simple mixture F1 F3 domains",
        "mesh_terms": [
            "Animals",
            "Mice",
            "Leishmania infantum",
            "Leishmaniasis Vaccines",
            "Leishmaniasis, Visceral",
            "Mice, Inbred BALB C",
            "Antigens, Protozoan",
            "Female",
            "Antibodies, Protozoan",
            "Vaccine Efficacy",
            "Protozoan Proteins",
            "N-Glycosyl Hydrolases",
            "Disease Models, Animal",
            "CD4-Positive T-Lymphocytes",
            "Leishmaniasis, Cutaneous",
            "Recombinant Fusion Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40666521/",
        "source_type": "Global"
    },
    {
        "pmid": "40664709",
        "title": "Molecular epidemiology, distribution, and determinants of cutaneous leishmaniasis in Northeast Ethiopia.",
        "abstract": "Cutaneous leishmaniasis CL common vectorborne neglected tropical disease caused protozoan parasite endemic Ethiopia Evidence molecular epidemiology CL community endemic area Ethiopia scarce study aimed investigate molecular epidemiology distribution determinant CL communitybased crosssectional study conducted March 2022 2023 356 suspected CL cases DNA extracted skinscraped samples Leishmania parasite detection specie identification performed via polymerase chain reaction PCR Variable multivariate binary logistic regression AORs p value ≤ 005 used identify determinant determine strength associations Among 384 suspected cases 356 included study resulting response rate 927 Among 356 suspected cases 253 711 positive Leishmania parasite according PCR Leishmania aethiopica causative agent CL study area confirmed CL case recorded among living poor housing conditions presence animal house AOR 206 95 CI 123343 age group  9 year AOR 294 95 CI 121714 age group 9 19 year AOR 323 95 CI 189551 size household five year AOR 278 95 CI 160484 statistically significant association CL study revealed CL major public health problem Northeast Ethiopia targeted tailored control strategy needed mitigate burden area",
        "mesh_terms": [
            "Ethiopia",
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Female",
            "Male",
            "Child",
            "Adult",
            "Adolescent",
            "Leishmania",
            "Cross-Sectional Studies",
            "Young Adult",
            "Child, Preschool",
            "Middle Aged",
            "Molecular Epidemiology",
            "Animals",
            "Infant",
            "Risk Factors",
            "Aged",
            "DNA, Protozoan"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40664709/",
        "source_type": "Global"
    },
    {
        "pmid": "40661166",
        "title": "Efficacy of meglumine antimoniate treatment on boxer <i>Leishmania infantum</i> skin lesions: case report.",
        "abstract": "clinical report describes beneficial effect local subcutaneous injection meglumine antimoniate Glucantime® iLeishmaniai cutaneous lesion dog Calabria region Southern Italy Leishmaniasis endemic zoonotic disease European Union particularly Mediterranean countries well part north east Africa India China Central South America caused protozoa genus iLeishmaniai spp infect several reservoirs including human domestic animals southern Europe main etiological agent iLeishmania infantumi transmitted sandfly subfamily Phlebotominae common cause cutaneous leishmaniasis CL regions dog considered primary domestic reservoir parasite 7yearold male nonsterilized Boxer named Ettore underwent prevaccination blood test Leishmania indirect immunofluorescence IFI test confirmed presence antibody protozoan iLeishmania infantumi antibody titer 11280 supporting diagnosis CL dog underwent therapeutic protocol consisting miltefosine Milteforan™  Virbac® 2 mgKg bw per os 28 day allopurinol 300 mg 10 mgKg bw po 6 months However end treatment period appearance suspicious skin lesion left tarsus reported appeared inflamed infected subsequent antibiotic antiinflammatory therapy based amoxicillinclavulanic acid 125 mgkg bw po 15 days metronidazole 75000UI  125 mg po 15 days prednisone 05 mgkg bw po 10 days failed effective thus lesion worsened also spread dorsal femoral surface hind limbs presenting blackish swollen painful alopecic oozing bloody purulent material Mild renal microlithiasis splenopathy reported abdominal ultrasound associated possible leishmania pattern Finally skin lesion experimentally treated subcutaneous injection Glucantime® 200 mglesion  05 mLlesion month 5 months followed complete healing Interestingly experimental localized treatment Glucantime® proved crucial counteracting Leishmania skin lesions result obtained suggest that appropriate diagnosis possible define targeted effective therapeutic protocol useful management canine leishmaniasis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40661166/",
        "source_type": "Global"
    },
    {
        "pmid": "40660056",
        "title": "Diagnostic Accuracy of Various Genetic Markers (tpi, gdh, and bg) for Prevalence and Genotyping of Giardia duodenalis in Human Samples: A Comparative Global Systematic Review and Meta-Analysis.",
        "abstract": "Giardia duodenalis widespread intestinal protozoan causing giardiasis human animals Precise detection genotyping parasite vital understanding epidemiology implementing appropriate treatments mitigating transmission Molecular techniques particularly multilocus genotyping MLG targeting betagiardin bg triose phosphate isomerase tpi glutamate dehydrogenase gdh genes improved diagnostic precision However variation sensitivity diagnostic performance among gene influence prevalence rate genotyping results particularly assemblage B common humans study evaluated pooled prevalence G duodenalis human sample confirmed positive microscopy andor small subunit ribosomal RNA SSU rRNA using bg tpi gdh genes comprehensive literature search identified 32 study MLG design published January 13 2025 encompassing 96 datasets 21 country four continents Data extraction quality assessment conducted independently two reviewers Metaanalyses employed randomeffects model using CMA software heterogeneity assessed via I² statistic Pooled prevalence diagnostic accuracy highest using tpi gene 643 95 CI 561718 followed gdh 597 95 CI 518671 bg 583 95 CI 498663 Nonetheless notable fraction microscopy andor SSU rRNAconfirmed sample undetected loci Assemblage B prevalent across genetic markers gdh gene showed superior sensitivity assemblage B 595 whereas bg slightly higher detection rate assemblage 416 finding underscore importance using multiple genetic marker precise detection genotyping tpi gene offer highest sensitivity overall prevalence among Giardiapositive samples gdh bg contribute critical assemblagespecific insights higher prevalence assemblage B underline need targeted public health strategies especially given association severe recurrent infections Overall integrating MLG SSU rRNA analysis essential improving diagnostics surveillance control strategy giardiasis globally",
        "mesh_terms": [
            "Humans",
            "Cytoskeletal Proteins",
            "Genetic Markers",
            "Genotype",
            "Genotyping Techniques",
            "Giardia lamblia",
            "Giardiasis",
            "Glutamate Dehydrogenase",
            "Prevalence",
            "Protozoan Proteins",
            "Sensitivity and Specificity",
            "Triose-Phosphate Isomerase"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40660056/",
        "source_type": "Global"
    },
    {
        "pmid": "40658390",
        "title": "Barbituric Acid Derivatives as Covalent Inhibitors of <i>Leishmania braziliensis</i> Dihydroorotate Dehydrogenase.",
        "abstract": "Covalent drug design applied parasite protein enables selective therapy targeting nucleophilic residue macromolecules present first covalent inhibitor iiLeishmania braziliensisii dihydroorotate dehydrogenase iLbiDHODH key enzyme pyrimidine biosynthesis reactive cysteine Cyssup131sup active site barbituric acid derivatives discovered b2ib iLbiDHODH inhibitor leishmanicidal activity exhibiting ICsub5subsub0sub 05 ± 01 μM KsubinactsubKiIi 767 Msup1supssup1sup inhibition human ortholog ECsub5subsub0sub 11 ± 5 μM iiL braziliensisii promastigotes cytotoxicity THP1 cell good passive permeability Xray crystallography confirms covalent bond formation Cyssup131sup reveals activesite rearrangements finding support proposed covalent inhibition mechanism provide structural insight optimization study validates iLbiDHODH promising target leishmaniasis therapy highlight potential covalent inhibition antiparasitic drug discovery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40658390/",
        "source_type": "Global"
    },
    {
        "pmid": "40658170",
        "title": "Knowledge, Attitudes, and Practices toward Cutaneous Leishmaniasis as a Neglected Tropical Disease among the General Population: A Systematic Review and Meta-Analysis.",
        "abstract": "Cutaneous Leishmaniasis CL tropical disease public health concern resulting infection Leishmania parasite transmitted bite infected female sandflies Community awareness essential component disease control prevention study aimed synthesize evidence knowledge attitudes practice CL among general population comprehensive literature search performed across multiple databases including PubMed Scopus Web Science EMBASE ScienceDirect Google Scholar Springer ProQuest study published English January 2025 Search term included MeSH freetext keywords related KAP toward CL quality included study assessed using NewcastleOttawa Scale NOS Data extracted randomeffects metaanalysis proportion applied pooling studies Heterogeneity explored subgroup sensitivity analyses certainty evidence evaluated using GRADE approach Knowledge assessed 47 study n  21930 attitude assessed 32 study n  13171 practice evaluated 30 study n  13729 CL Overall general population estimated 54595 CI 478 611 good knowledge CL positive attitude 562 95 CI 485 638 practically 495 95 CI 403538 substantial heterogeneity observed study I2  98 cases European region highest level knowledge 753 Southeast Asia region positive attitude 656 good practice Eastern Mediterranean region 459 Metaregression analysis indicated year publication significantly associated heterogeneity knowledge attitude outcomes contrast region significantly associated heterogeneity practice outcome p  005 According GRADE approach overall certainty evidence moderate knowledge attitude outcomes high practice outcomes level knowledge attitude practice general population regarding CL desired level many regions especially endemic countries result emphasize need design implement educational intervention targeted awareness program promote public KAP CL especially area high prevalence low practice",
        "mesh_terms": [
            "Humans",
            "Health Knowledge, Attitudes, Practice",
            "Leishmaniasis, Cutaneous",
            "Neglected Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40658170/",
        "source_type": "Global"
    },
    {
        "pmid": "40657022",
        "title": "Diagnostically Challenging Case: Coexistence of Two Zoonoses.",
        "abstract": "male patient presented fever cytopenia hepatosplenomegaly patients iBrucellai tube agglutination test positive titer 1640 Due lack response brucellosis treatment additional test performed iLeishmaniai amastigotes seen second bone marrow biopsy preparations iLeishmaniai PCR positive visceral leishmaniasis VL diagnosed Here present case VL brucellosis coinfection presented B symptom fever night sweats weight loss cytopenia difficult diagnose",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40657022/",
        "source_type": "Global"
    },
    {
        "pmid": "40656817",
        "title": "Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous <i>Leishmania Braziliensis</i> in a Recent Traveler in Belize and Guatemala.",
        "abstract": "report case 53yearold male recent travel Guatemala Belize diagnosed cutaneous leishmaniasis CL treated empirically miltefosine improvement switched amphotericin B upon specie identification iL braziliensisi resulting resolution lesions case demonstrates clinician recognize importance systemic therapy treating complex CL well importance identification specie type tailoring treatments Furthermore miltefosine proven efficacious CL many New World locales demonstrated lower cure rate CL Guatemala thus identification region origin CL infection imperative guiding treatment may vary according difference drug potency regionspecific resistance rates",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40656817/",
        "source_type": "Global"
    },
    {
        "pmid": "40655011",
        "title": "Dysregulated lymphatic remodeling promotes immunopathology during non-healing cutaneous leishmaniasis.",
        "abstract": "Cutaneous leishmaniasis CL vector borne disease endemic tropical subtropical region world disproportionately affecting low socioeconomic status combined role parasite hosts immune response determining disease severity made challenging discover new antileishmanial treatments Previous work lab established dermal lymphatic network necessary wound resolution model healing CL iLeishmania majori parasites CL lymphatic remodeling allows accumulated fluid drain lesional site thereby reducing disease severity report present new mechanism immunopathology nonhealing CL brought iL amazonensisi infection show nonhealing CL develops alongside accumulation cell fluid skin resulting chronic inflammation Lymphatic remodeling attenuated chronic phase iL amazonensisi infection Moreover percentage proliferating lymphatic endothelial cell LECs decrease 6 12 week post infection wpi leading decrease time lymphatic vessel LV density induce lymphangiogenesis exogenous vascular endothelial growth factorC VEGFC administered adenoviral delivery VEGFC increased LV dilation leading reduced lesion size without altering parasite burdens arguing targeting lymphatics alleviate immunopathology Taken together result show impaired lymphatic function contributes nonhealing disease due iL amazonensisi infection lymphatics targeted decrease inflammation skin infection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655011/",
        "source_type": "Global"
    },
    {
        "pmid": "40655006",
        "title": "An oviposition pheromone, hexadecanoic acid, found on the eggs of <i>Phlebotomus papatasi</i> from Central Tunisia, attracts gravid females and stimulates oviposition.",
        "abstract": "iPhlebotomus papatasii vector iLeishmania majori etiologic agent zoonotic cutaneous leishmaniasis disfiguring debilitating disease study identified fatty acid found exterior egg laid female iP papatasii could potential oviposition pheromones tested effect different treatment 1 number egg laid 2 spatial distribution egg laid treatment included three quantity egg 80 160 320 hexane extract 160 eggs 160 egg washed hexane remove pheromones three concentration 1ng 10ng 100ng synthetic version three fatty acid identified present egg exteriors saturated fatty acid dodecanoic C12 tetradecanoic C14 acid identified GCMS analysis abundant hexane extract egg gravid female present trace amount males Hexadecanoic hexadecenoic C16 acid abundant eggs gravid female males negative binomial GLM found significantly egg oviposited gravid female response 80 egg iPi00255 160 egg iPi0001 320 egg iPi0001 hexane extract 160 egg iPi0001 Eggs washed hexane attractive control iPi0591 number egg laid increased three concentration hexadecanoic acid iPi0001 10ng 100ng tetradecanoic acid iPi0001 1ng 10ng dodecanoic acid iPi0001 spatial response oviposition the proportion egg laid test vs control side oviposition pot weaker response total egg laid beta GLM found gravid female laid significantly higher proportion egg near 160 egg iPi0004 significantly lower proportion egg near 100ng dodecanoic acid iPi0016 Bootstrapping permutation test also suggested significant attractive effect 320 eggs egg extract 1ng 10 ng hexadecenoic acid result suggest hexadecanoic acid oviposition pheromone iP papatasii Tunisia presence increase number egg laid attracts oviposition small spatial scale assay Studies others shown dodecanoic acid oviposition pheromone iP papatasii Turkey study dodecanoic acid increased number egg laid either change spatial distribution repulsive highest concentration observed difference may related different geographical origin sand fly used study",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655006/",
        "source_type": "Global"
    },
    {
        "pmid": "40654248",
        "title": "In Vitro Leishmanicidal Efficacy of Synthesized Arylidene Analogues of Glitazone.",
        "abstract": "Diabetes fastgrowing health issue low middleincome countries 80 diabetic living tropic subtropics deadly condition claiming life million individual annually therapeutic treatment available date management diabetes thus limited symptomatic relief glycemic control Furthermore geographical overlap diabetes neglected tropical disease NTDs concern diabetes known increase infection susceptibility severity contrast diabetesinfection comorbidity negatively affect treatment responses Leishmaniasis rank among top 10 NTDs current therapeutic treatment relies handful drug marred two main shortcomings toxicity reduced efficacy due pathogenic resistance Hence pressing need new effective antileishmanial therapeutics evidence rising case leishmaniasisdiabetes coinfection may require use dualactive therapeutic curb them search new effective antileishmanial agent potential dual use evaluated vitro antileishmanial antidiabetic activity series arylidenes derived hydantoin glitazone rhodanine scaffold using phenotypic assays previously investigated antidiabetic potential Additionally antitrypanosomal potential compound also considered due taxonomic relation Leishmania Trypanosoma spp reported concern Chagas disease human African trypanosomiasisdiabetes comorbidities Three leishmanicidal early lead submicromolar activity uncovered antitrypanosomal dual leishmaniasisdiabetes active hit identified",
        "mesh_terms": [
            "Antiprotozoal Agents",
            "Animals",
            "Humans",
            "Hypoglycemic Agents",
            "Thiazolidinediones",
            "Leishmaniasis",
            "Leishmania",
            "Parasitic Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40654248/",
        "source_type": "Global"
    },
    {
        "pmid": "40650542",
        "title": "Designing drugs against leishmaniasis: is targeting the sterol biosynthesis pathway the answer?",
        "abstract": "Leishmaniasis devastating complex parasitic disease caused different specie protozoan member genus iLeishmaniai Unfortunately available drug far ideal vaccine available circumstances new effective antileishmanial drug reduced host toxicity improved dosing protocol urgently needed sterol biosynthesis pathway SBP promising focus combating iLeishmaniai infections Thus various strategy documented drug repurposing combined therapy rational drug design use synergistic effect develop metallodrugs act essential parasite targets article review critical enzyme participating ergostanebased sterol biosynthesis pathway SBP iLeishmaniai species well recent progress rational drug design repurposing drugs combined therapies development metallodrugs use antileishmanial agents review based literature searcher using SciFinder Lensorg Google Scholar Web Science Pub Med DrugBank limited focus human leishmaniasis resulted shortfall effective treatment parasitic disease postsqualene segment sterol biosynthetic pathway promising target treating iLeishmaniai infections particularly effective drug metallodrugs inhibit CYP51 24SMT enzymes",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis",
            "Leishmania",
            "Antiprotozoal Agents",
            "Sterols",
            "Drug Design",
            "Animals",
            "Drug Repositioning",
            "Biosynthetic Pathways",
            "Drug Development"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40650542/",
        "source_type": "Global"
    },
    {
        "pmid": "40645246",
        "title": "Antibody functionalized thiolated chitosan stabilized silver nanoparticles as theranostics toward visceral leishmaniasis.",
        "abstract": "Leishmaniasis VL neglected disease caused Leishmania protozoa transmitted insect vectors fatal without adequate treatment Current therapy hindered issue drug resistance side effects making rapid diagnosis essential Biosensors explored enhance detection silver nanoparticles AgNPs emerged promising tool diagnosis treatment improve stability functionality AgNPs coated thiolated chitosan TCh synthesized introducing thiol group chitosan using 3mercaptopropionic acid confirmed sup1supH NMR FTIR analysis TChstabilized AgNPs TChAgNPs created using chemical reduction method resulting nanoparticles mean diameter 66 ± 1 nm maximum absorbance peak 418 ± 2 nm AntirK39 antibody anchored nanoparticles TChAgNPsAb showed enhanced interaction kinetics rK39 protein compared free antibodies indicated 23 time stronger signal Additionally TChAgNPs demonstrated greater antileishmanial activity cell culture compared control groups result suggest TChAgNPs could serve valuable platform developing sensitive diagnostics effective treatment VL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40645246/",
        "source_type": "Global"
    },
    {
        "pmid": "40642881",
        "title": "Evaluation of itraconazole monotherapy versus its combination with a single dose of pentamidine for treating cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Amazonas state, western Brazilian Amazon.",
        "abstract": "Cutaneous leishmaniasis long neglected tropical disease mainly due therapy limitations search safe effective alternative treatments particularly oral medications led development secondline treatments azole antifungals including itraconazole study aimed evaluate compare therapeutic effectiveness itraconazole alone combination pentamidine patient cutaneous leishmaniasis caused Leishmania Viannia guyanensis randomised clinical trial conducted leishmaniasis outpatient clinic Fundação de Medicina Tropical Doutor Heitor Vieira Dourado Manaus Amazonas Ninety eligible patient diagnosed cutaneous leishmaniasis selected randomly assigned three treatment groups Control groupGroup 1 G1 received pentamidine isethionate experimental groupGroup 2 G2 received itraconazole monotherapy experimental groupGroup 3 G3 received combination itraconazole one dose pentamidine isethionate standardised doses Patients monitored 30 60 90 180 day completion treatment Leishmania specie identified using biomolecular methods patient predominantly male 844 mean age 405 ± 129 years 93 case originated peripheral area Manaus Amazonas average duration skin lesion evolution 30 days 84 presenting ulcerated lesions single lesion observed 57 cases 41 measured 2 3 cmsup2sup predominantly lower limbs Four specie Leishmania identified L guyanensis causing 90 cases L brasiliensis causing 6 cases L amazonensis causing 25 case L naiffi causing 12 cases Among 72 case L V guyanensis cure rate 96 itraconazole  pentamidine 83 itraconazole alone 58 pentamidine alone serious adverse event observed term toxicity tolerability Injection site pain induration common adverse effect G1 term efficacy patient G2 G3 experienced favourable outcomes 90day cure rate 56 G1 73 G2 90 G3 90 days itraconazolepentamidine combination therapy effective 90 either itraconazole pentamidine alone cutaneous leishmaniasis Amazonas state caused L guyanensis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40642881/",
        "source_type": "Global"
    },
    {
        "pmid": "40642251",
        "title": "Telemedicine in the clinical care of Chagas disease and American cutaneous leishmaniasis: pilot study in a public referral hospital in Brazil.",
        "abstract": "Neglected tropical disease NTDs remain major public health challenge low middleincome country LMICs especially rural underserved regions Although telemedicine expanded globally evidence implementation individual clinical care NTDs remains scarce pilot implementation study aimed assess feasibility acceptability synchronous telemedicine consultation patient Chagas disease CD American Cutaneous Leishmaniasis ACL national reference hospital Brazil conducted mixedmethods implementation study using Design Science Research Methodology DSRM context analysis involved structured survey 31 health professional semistructured interview two local managers Patients diagnosed CD ACL recruited August October 2024 Teleconsultations performed via WhatsApp video call four specialists Patient satisfaction evaluated using structured questionnaires 46 patient recruited 38 826 completed teleconsultations older adult prior telehealth experience Despite low digital literacy education levels 632 2438 completed teleconsultation without assistance High level satisfaction reported 974 3738 satisfied would attend future virtual visits Participants reported reduced travel burden improved access care major technical issue observed Synchronous telemedicine via lowcost widely available platform feasible wellaccepted clinical followup CD ACL Brazilian public hospital approach may help reduce access barrier specialized care NTDs research evaluate clinical outcome costeffectiveness LMIC settings",
        "mesh_terms": [
            "Humans",
            "Brazil",
            "Pilot Projects",
            "Telemedicine",
            "Female",
            "Male",
            "Adult",
            "Chagas Disease",
            "Middle Aged",
            "Leishmaniasis, Cutaneous",
            "Patient Satisfaction",
            "Hospitals, Public",
            "Surveys and Questionnaires",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40642251/",
        "source_type": "Global"
    },
    {
        "pmid": "40637365",
        "title": "Relationship Between Hepcidin, Iron Metabolism, Inflammation and Hypersplenism in Anaemia of Kala-Azar.",
        "abstract": "Kalaazar visceral leishmaniasis VL parasitic disease caused Leishmania spp characterised fever weight loss splenomegaly hepatomegaly anaemia study evaluated relationship hepcidin inflammation iron metabolism hypersplenism VLassociated anaemia crosssectional study confirmed VL patient without recent transfusion assessed Haematological inflammatory parameter analysed using correlation multivariate regression tests Anaemia present 952 sample predominantly normocytic 595 normochromic 762 microcytic 405 hypochromic 238 Inflammatory marker markedly elevated patients particularly hepcidin increased 976 case median 35146 ngmL suggesting persistent inflammation impaired iron bioavailability However IL6 CRP ferritin showed weak moderate negative correlation hepcidin ρ  033 ρ  066 ρ  030 respectively finding highlight complex interplay anaemia inflammation kalaazar elevated hepcidin level paradoxical correlation inflammatory markers underscore central role splenomegaly VLrelated anaemia suggest potential contribution factor affecting iron metabolism erythropoietin erythroferrone Understanding dynamic marker throughout disease progression treatment may elucidate pathophysiology VL support development targeted therapies",
        "mesh_terms": [
            "Humans",
            "Hepcidins",
            "Leishmaniasis, Visceral",
            "Female",
            "Cross-Sectional Studies",
            "Male",
            "Adult",
            "Anemia",
            "Iron",
            "Inflammation",
            "Middle Aged",
            "Hypersplenism",
            "Young Adult",
            "Adolescent",
            "Biomarkers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40637365/",
        "source_type": "Global"
    },
    {
        "pmid": "40632305",
        "title": "Investigating the impact of HIS-1 and HSP-70 genes on drug response and pathology of Leishmania major using antisense oligonucleotides.",
        "abstract": "Leishmaniasis protozoan disease caused protozoan Leishmania spp present wide spectrum manifestations Researchers currently unable control treat different form leishmaniasis effective vaccine treatment yet available study aimed assess pathological aspect drug susceptibility L major treated antisense oligonucleotides ASO targeting HSP70 HIS1 genes study investigates antileishmanial property antisense oligonucleotides ASO directed HSP70 HIS1 genes play critical role stage differentiation resistance antileishmanial drugs experiment conducted using L major promastigotes amastigotes vitro mouse model cutaneous leishmaniasis CL result indicated expression HSP70 HIS1 gene significantly reduced group receiving antisense oligonucleotides ASO group treated HSP70 ASO amastigote count macrophage significantly reduced compared groups finding vivo experiment revealed group receiving HIS1 ASO size CL lesion significantly reduced susceptibility glucantime significantly increased compared groups result current study demonstrated HIS1 HSP70 ASOs successfully inhibit pathogenicity L major decrease lesion size CL ASO novel technique genetic manipulation also revealed aid control prevention various diseases",
        "mesh_terms": [
            "Animals",
            "Oligonucleotides, Antisense",
            "HSP70 Heat-Shock Proteins",
            "Leishmania major",
            "Mice",
            "Leishmaniasis, Cutaneous",
            "Antiprotozoal Agents",
            "Mice, Inbred BALB C",
            "Protozoan Proteins",
            "Disease Models, Animal",
            "Female",
            "Macrophages"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40632305/",
        "source_type": "Global"
    },
    {
        "pmid": "40631203",
        "title": "Guanylate-Binding Proteins Promote Host Defense Against <i>Leishmania major</i> by Balancing iNOS/Arg-1 in Myeloid Cells.",
        "abstract": "Cutaneous leishmaniasis CL debilitating neglected tropical disease characterized lesion range selfhealing permanent disfigurations predominant Th1 response stimulates IFNγ production crucial parasite control selfhealing CL IFNγ primarily activates macrophage produce nitric oxide via inducible nitric oxide synthase iNOS leading parasite control IFNγ also activates downstream pathway involved cell autonomous immunity One pathway activation guanylate binding protein GBPs class interferon inducible GTPases However role GBPs CL minimally explored Utilizing RNASeq found iLeishmania majori infection lead upregulation several GBPs C57Bl6 mice vitro study using GBPChr3 knockout KO C57Bl6 control mouse reveal bone marrowderived macrophage BMDMs KO mouse exhibit higher parasite burden following IFNγ treatment independent GBP localization parasite Singlecell RNASeq identifies macrophage primary expressers GBPs iL majori infection iin vivoi iIn vivoi GBPChr3 KO mouse display increased disease severity parasite load GBPChr3 KO macrophage monocyte show elevated ARG1 reduced iNOS expression indicating shift toward parasitepermissive environment support parasite growth finding highlight critical role GBPs immunemediated control CL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40631203/",
        "source_type": "Global"
    },
    {
        "pmid": "40628941",
        "title": "Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis.",
        "abstract": "drug discovery pipeline neglected kinetoplastid disease remains sparse particular field leishmaniasis drug discovery limited success translating potential drug candidate viable therapies Here describe development two lead compounds BZ1 BZ1I potent vitro antileishmanial activity Leishmania donovani DD8 intracellular amastigotes 059 ± 013 µM 040 ± 038 µM corresponding selectivity   3389  4912 differentiated THP1 cell Human monocytic cell line respectively characterization biological profiling identified addition activity L donovani DD8 Old World  Indian strain compound active intracellular parasite specie strain Old New World namely L donovani Old World  Sudanese strain L infantum chagasi New WorldSouth American strain vivo evaluation using hamster model illustrated activity observed vitro translated vivo outstanding results data suggests compound represent promising starting point developing novel lead series future antileishmanial therapeutics",
        "mesh_terms": [
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Leishmania infantum",
            "Animals",
            "Humans",
            "Antiprotozoal Agents",
            "Cricetinae",
            "THP-1 Cells",
            "Drug Discovery"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40628941/",
        "source_type": "Global"
    },
    {
        "pmid": "40627779",
        "title": "Prevalence of Leishmania infection in refugee camps: A serological and molecular study in Gambella and Benishangul-Gumuz, Ethiopia.",
        "abstract": "Leishmaniasis transmitted sandflies cause severe health threat East African refugee camps High mobility poor condition limited healthcare access heighten risk visceral leishmaniasis VL among refugees Though data infection prevalence remains limited study aim determine prevalence Leishmania infection refugee camp Benishangul Gumuz Gambella region improve VL detection guide effective control strategy humanitarian settings crosssectional study conducted May August 2023 four refugee camp determine Leishmania infection using DAT rtPCR blood samples Sociodemographic clinical data collected using structured questionnaires Ethical approval granted informed consent obtained Data analyzed using SPSS v23 association assessed using logistic regression Chisquare test 005 significance level Continuous variable summarized median interquartile range IQR study included 1223 participant 440 Tsore camp 220 Sherkole Benishangul Gumuz Region 288 Kule camp 275 Terkidi Gambella Region South Sudan 667 majority female 565 178 participant reported fever spleen liver enlargement 02 lymph node swelling Realtime PCR positivity significantly higher Tsore 146 χ²  214 p  0001 significant difference DAT positivity observed across refugee camp χ²  66 p  0084 Leishmania DAT positivity rate 60 46 47 fever chill headache respectively Leishmania kDNA based rtPCR positivity rate 117 88 73 62 fever chills headache weakness respectively Participants Benishangul Gumuz region AOR 367 95CI 157859 p  0003 South Sudanese AOR 287 95CI 126650 p  0012 fever AOR 208 95CI 101428 p  0047 higher odds DAT positivity hand lower rtPCR positivity rate seen Sherkole refugee camp compared Tsore camp Benishangul Gumuz region AOR 019 95CI 008045 p  00001 Leishmania infection prevalent refugee camp Gambella Benishangul Gumuz regions Asymptomatic case low parasite load common highlighting need active case detection intervention including treatment vector control manage VL transmission effectively",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Refugee Camps",
            "Adult",
            "Prevalence",
            "Adolescent",
            "Young Adult",
            "Child",
            "Ethiopia",
            "Middle Aged",
            "Child, Preschool",
            "Refugees",
            "Leishmania",
            "Seroepidemiologic Studies",
            "Leishmaniasis, Visceral",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40627779/",
        "source_type": "Global"
    },
    {
        "pmid": "40622619",
        "title": "In Vitro Anti-Leishmanial Activity and Molecular Docking of Eugenol as a Potential Agent Against Leishmania Major.",
        "abstract": "Eugenol aromatic compound belongs phenol group found various natural sources clove oil study aimed investigate eugenols leishmanicidal activity mechanism action using molecular docking predict potential biochemical target eugenol Leishmania major interaction eugenol TNFαIL12p40 evaluated using docking methods leishmanicidal activity eugenol Glucantimesup®sup MA combination assessed promastigote amastigote stage Leishmania major Additionally realtime PCR used measure cytokine gene expression level murine macrophage treated studied drugs ICsub50sub value eugenol MA combination L major promastigotes determined 23522 µgmL 29893 µgmL 15902 µgmL respectively Regarding antiamastigote activity combination eugenol exhibited lowest ICsub50sub value 417 µgmL compared 731 µgmL eugenol alone combination ICsub50sub located line showed additivity role Docking study suggest residue within active site eugenol capable interacting TNFα IL12p40 Specifically Leu57 Leu120 Gly120 Gly122 identified common amino acid involved binding eugenol TNFα whereas Glu12 Asn200 His83 associated eugenols interaction IL12p40 Gene expression analysis revealed upregulation Th1 cytokine IL12P40 iNOS IFNγ downregulation Th2 cytokine IL4 IL10 combined treatment relative individual treatments superior efficacy combined treatment eugenol L major necessitates research clinical potential combination treatment leishmaniasis",
        "mesh_terms": [
            "Eugenol",
            "Molecular Docking Simulation",
            "Animals",
            "Mice",
            "Leishmania major",
            "Antiprotozoal Agents",
            "Tumor Necrosis Factor-alpha",
            "Macrophages",
            "Cytokines",
            "Interleukin-12 Subunit p40",
            "Inhibitory Concentration 50"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40622619/",
        "source_type": "Global"
    },
    {
        "pmid": "40620982",
        "title": "Amine-Functionalized Graphene Quantum Dots Conjugated with Amphotericin B: Synthesis, Characterization, and In Vitro Evaluation for Visceral Leishmaniasis Treatment.",
        "abstract": "Visceral Leishmaniasis VL lifethreatening parasitic disease primarily affecting population resourcelimited endemic regions Existing treatment VL face limitation toxicity high costs suboptimal efficacy specific patient groups Given lack vaccine chemotherapy remains option emphasizing urgent need safer effective treatments Nanotechnology offer promising avenue overcome challenges study introduces novel approach involving aminefunctionalized graphene quantum dot fGQDs conjugated Amphotericin B fGQDAmB enhance targeted drug delivery infected macrophages novel approach could lead safer effective treatment VL significant contribution field Structural characterization XRD FTIR confirmed successful GQD synthesis functionalization cellular assay demonstrated significantly higher macrophage uptake enhanced antileishmanial efficacy fGQDAmB demonstrated approximately 42fold greater potency intracellular amastigotes 2fold higher efficacy promastigotes also exhibiting reduced cytotoxicity compared conventional AmB safety effectiveness fGQDAmB validated hemolysis assay providing reassurance confidence potential use instilling confidence potential Quantum Dotbased Nanomedicine formulations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40620982/",
        "source_type": "Global"
    },
    {
        "pmid": "40618369",
        "title": "Potent antileishmanial and synergic effects of phellandrene through its immunomodulation, modulating oxidant/antioxidant, and apoptotic induction.",
        "abstract": "primary pharmaceutical treatment cutaneous leishmaniasis CL linked range negative complications development innovative pharmacological agent aimed enhancing cellular immune response could denote promising therapeutic approach CL therapy Here present study investigated impact phellandrene PR cyclic monoterpene found various plant species Leishmania tropica focusing antileishmanial properties immunomodulatory effects antioxidant activity capacity induce apoptosis antileishmaial synergistic property effect PR alone conjunction glucantime GCT L tropica promastigote amastigote form investigated well influence PR immunomodulatoryassociated genes antioxidantassociated genes plasma membrane integrity ROS generation apoptosis induction nitric oxide NO production assessed found PR principally conjunction GCT notably reduced number promastigote amastigote form within macrophage dosedependent reduction plt0001 found significant upregulation expression iNOS interferon gamma IFNg tumor necrosis factor TNFa gene infected macrophage subsequent treatment RP particularly conjunction GCT Conversely notable downregulation expression interleukin 10 IL10 superoxide dismutase SOD catalase CAT genes whereas result substantial rise release macrophage cell p0001 PR GCT PRGCT resulted dosedependent enhancement caspase3 activity increase plasma membrane integrity reactive oxygen specie ROS production p0001 finding indicate PR mainly along GCT substantial effect inhibition elimination Leishmania parasite controlled laboratory environments Although certain cellular mechanism action recognized including immune modulation cellular immunity response induction apoptosis ROS production reducing antioxidant activity affecting membrane integrity response Leishmania additional research required interpret effectiveness animal model human participants",
        "mesh_terms": [
            "Apoptosis",
            "Antioxidants",
            "Animals",
            "Antiprotozoal Agents",
            "Monoterpenes",
            "Leishmania tropica",
            "Mice",
            "Drug Synergism",
            "Nitric Oxide",
            "Macrophages",
            "Meglumine Antimoniate",
            "Immunomodulation",
            "Reactive Oxygen Species",
            "Oxidants"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40618369/",
        "source_type": "Global"
    },
    {
        "pmid": "40615842",
        "title": "Retrospective study of canine leishmaniosis in Israel.",
        "abstract": "Canine human leishmaniasis prevalent around Mediterranean Basin dog considered main peridomestic reservoir human disease Canine leishmaniosis initially diagnosed central Israel 1994 Since then routinely detected canine population Israel small number human case reported annually retrospective analysis dog diagnosed Leishmania infection Hebrew University 1994 December 2023 included 658 dogs Although infected dog reported 16 subdistricts Israel geographic distribution location infected dog focused mainly central northern Israel 2020 isolated case also detected southern Israel suggesting southward spread disease majority infected dog n  341 518 resident rural localities remainder n  267 406 present urban areas highest number case found Jerusalem Subdistrict highest density infected dogs case per square km present Tel Aviv Subdistrict incidence rate clinical leishmaniosis year 20072023 based Israeli dog registry ranged 003 009 per 1000 registered dogs 353 dog diagnosed 2013 onward age ranged 3 month 145 year median 45 years 38 dog also tested polymerase chain reaction PCR Leishmania spp since 2010 32 84 infected L infantum 4 11 L tropica 2 5 L major epidemiology canine leishmaniosis caused mostly L infantum present contrary picture human leishmaniasis Israel 99 patient reported cutaneous leishmaniasis caused mostly L major L tropica less 1 visceral disease due L infantum widespread presence canine L infantum infection central northern Israel constitutes zoonotic reservoir disease humans wildlife cats dogs",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Israel",
            "Dog Diseases",
            "Retrospective Studies",
            "Leishmaniasis",
            "Male",
            "Female",
            "Humans",
            "Incidence",
            "Leishmania infantum",
            "Leishmania",
            "Leishmaniasis, Visceral"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40615842/",
        "source_type": "Global"
    },
    {
        "pmid": "40613607",
        "title": "Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy.",
        "abstract": "Cutaneous leishmaniasis present significant challenge public health due diverse clinical manifestations resistance development treatmentrelated adverse effects Here examined efficacy ivermectin moxidectin MOX afoxolaner permethrin stage Leishmania tropica THP1 cells also assessed potential resistance acquisition 15 round artificial selection elucidate mode action MOX employed RNA sequencing molecular dynamic simulation chloride flux assays Additionally evaluated therapeutic index MOX using Galleria mellonella infection model MOX demonstrated highest selectivity index leishmaniasis promastigotes 058 μM amastigotes 096 μM host cells 6029 μM Moreover MOX exhibited lowest resistance acquisition promastigotes intracellular amastigotes 15 round artificial selection resistance ratio 1723 459 respectively Postexposure MOX differential gene expression profile showed stagespecific stageunspecific enrichment gene family involved crucial biological processes Moreover molecular dynamic simulation revealed potential neutralizing effect MOX chloride channel L tropica Specifically MOX bind selectivity filter potentially disrupting osmotic equilibrium thereby killing parasite vivo introduction MOX significantly inhibited growth L tropica G mellonella larvae resulting decreased rate mortality melanization finding indicate MOX promising candidate treatment L tropica infections warranting investigation potential consideration clinical use",
        "mesh_terms": [
            "Animals",
            "Leishmaniasis, Cutaneous",
            "Humans",
            "Macrolides",
            "Leishmania tropica",
            "Drug Repositioning",
            "Molecular Dynamics Simulation",
            "Antiprotozoal Agents",
            "Drug Resistance",
            "Moths",
            "Ivermectin",
            "Cell Line",
            "Permethrin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40613607/",
        "source_type": "Global"
    },
    {
        "pmid": "40611204",
        "title": "Enhancing protection against vector-borne diseases in forcibly displaced communities: evaluating the efficacy of spatial repellents for cutaneous leishmaniasis control in North-East Syria.",
        "abstract": "Syria 14 year outbreak civil war 167 million people forced flee homes 72 million remain internally displaced 2025 Breakdown waste management caused aerial bombardment created ideal condition cutaneous leishmaniasis CL transmission vectored phlebotomine sandflies Displaced population reside flimsy shelter conventional vector control tool operationally unfeasible small lightweight portable transfluthrinbased spatial repellent Mosquito Shield™ developed may circumvent logistical issue provide improved protection vectorborne disease harsh environments twoarm nonrandomised cluster trial undertaken ArRaqqa governorate NorthEast Syria evaluate efficacy Mosquito Shield™ reducing CL case incidence sandfly density shelters Weekly epidemiological monitoring performed MENTOR Initiative mobile clinic supported health facilities Entomological monitoring performed fortnightly using indoor US Centers Disease Control Prevention light trap 40 randomly selected household per study arm Phlebotomine sandfly morphologically identified subset analysed molecular specie confirmation bloodmeal preference pyrethroid resistance Household survey focus group discussion used assess intervention feasibility acceptability uptake Assuming 2month diagnosis cutoff CL incidence rate 99 52 per 1000 control intervention arms respectively Mosquito Shield™ demonstrated significant impact rate CL infection age incidence rate ratio IRR 052 95 CI 037074 p  00001 Mosquito Shield™ demonstrated significant impact female sandfly density IRR 022 95 CI 014033 p  00001 bloodfed female sandfly density IRR 021 95 CI 011040 p  00001 Mosquito Shield™ received positively perceived easy use protect CL sandfly insect bite required minimal behaviour change Trial finding provide first demonstrable impact spatial repellent CL transmission strengthening growing evidence basis effectiveness intervention multiple vector specie associated pathogens Study result strongly support deployment spatial repellent control CL humanitarian crises ClinicalTrialsgov NCT06917040",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Animals",
            "Child",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Young Adult",
            "Insect Repellents",
            "Leishmaniasis, Cutaneous",
            "Psychodidae",
            "Syria",
            "Vector Borne Diseases",
            "Cyclopropanes",
            "Fluorobenzenes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40611204/",
        "source_type": "Global"
    },
    {
        "pmid": "40610818",
        "title": "High-throughput screening identifies novel chemical scaffolds targeting Leishmania donovani parasites.",
        "abstract": "Highthroughput screening HTS one critical strategy accelerate process drug discovery exploring small druglike molecule libraries HTS noticeably contributes identification potential hit using various automation tool biological assays Leishmaniasis neglected tropical disease one deadly protozoan parasitic infection causing significant global burden certain povertystricken countries Given paucity effective chemotherapeutic agent available treatment lifethreatening infection discovery novel leishmanicidal scaffold innovative strategy pivotal combating parasitic disease present study employed HTS strategy scrutinize 10000 druglike molecule inhouse ChemDiv library identify potent hit Leishmania donovani Noticeably 99 molecule showed  80 inhibitory effect L donovani parasite 50 µM concentration among them four molecule displayed 50 inhibitory concentration ICsub50sub value  10 µM along favorable selectivity index  10 Scanning electron microscopy analysis suggests potent hit cause considerable morphological alterations predicted ADME pharmacokinetics study potent hit molecule indicates hit considerable druglikeness property showed low risk adverse effects along predicted high level oral bioavailability Thus promising hit identified HTS strategy serve initial basis consequent medicinal chemistry endeavor aimed unraveling new series antileishmanial agents",
        "mesh_terms": [
            "Leishmania donovani",
            "High-Throughput Screening Assays",
            "Antiprotozoal Agents",
            "Animals",
            "Small Molecule Libraries",
            "Drug Discovery",
            "Inhibitory Concentration 50",
            "Parasitic Sensitivity Tests",
            "Leishmaniasis, Visceral",
            "Humans"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40610818/",
        "source_type": "Global"
    },
    {
        "pmid": "40608248",
        "title": "Examining miR-196a, miR-196b and NF-κBIα gene expression in colitis mice model.",
        "abstract": "Bifidobacterium bifidum B bifidum antiinflammatory characteristic ability modify gut microbiota make promising treatment option Inflammatory Bowel Disease IBD present study investigated modulatory effect B bifidum expression miR196a miR196b NFκBIα gene DSSinduced IBD mouse model Thirty male C57BL6 mouse randomly assigned five experimental group G1G5 induction colitis used 3 DSS drinking water 8 days Disease Activity Index DAI monitored mouse euthanized analysis 22nd day mouse gavaged 2 × 10sup9sup CFUml B bifidum per day Histological grading colon tissue done level cytokine TNFα IL6 measured using ELISA gene level expression miR196a miR196b NFκBIα analyzed RTPCR Weight gain day 11 17 G3 G4 B bifidum treatment pointed therapeutic benefits Colon length weight spleen weight significantly decreased G2 compared G1 P ≥ 00001 Histopathological examination revealed severe mucosal damage G2 reduced inflammation G3 fewer deep wound G4 significant healing G5 B bifidum especially G5 significantly reduced IL6 TNFα level P ≥ 00002 Gene expression analysis showed decrease miR196a NFκBIα increase miR196b G5 showing change P ≥ 00001 conclusion B bifidum demonstrated significant antiinflammatory effect DSSinduced IBD model modulating miRNA expression reducing key inflammatory cytokines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40608248/",
        "source_type": "Global"
    },
    {
        "pmid": "40606630",
        "title": "Oregano essential oil <i>(Origanum vulgare)</i> induces death in a resistant strain of <i>Leishmania infantum</i> isolated from a naturally infected dog through increased production of reactive oxygen species, mitochondrial damage and cell metabolic disruption.",
        "abstract": "Leishmaniasis neglected tropical disease caused protozoa iLeishmaniai genus transmitted phlebotomine sandflies Clinical manifestation vary depending parasites specie hosts immune system ranging selfhealing skin lesion lethal visceral diseases Visceral leishmaniasis VL mainly caused iL infantumi iL donovanii serious public health issue Conventional treatment challenging due toxicity long duration resistance highlighting need alternative therapies Oregano essential oil OEO biological effects including antibacterial antifungal antioxidant actions making potential leishmanicidal agent evaluate activity promastigotes two iL infantumi strain tested MS from naturally infected dog Brazil reference strain MCANBR97p142 IC50 value 1253 µgmL 4361 µgmL respectively amphotericin B AmB showed lower IC50 value 01453 µgmL 02126 µgmL OEO treatment increased reactive oxygen specie ROS production mitochondrial damage lipid droplet accumulation autophagic vacuoles indicating intense cellular stress Additionally apoptosis marker phosphatidylserine exposure membrane permeabilization detected Fluorescence scanning SEM transmission TEM microscopy revealed morphological ultrastructural alterations including membrane blebbing flagellar damage intracellular content leakage mitochondrial swelling assess antiamastigote effect THP1 cell infected iL infantumi strain treated OEO MS strain showed lower infection rate higher parasite load per macrophage tested concentration 25 50 75 μgmL reduced number infected macrophage intracellular amastigotes Thus OEO exhibit leishmanicidal activity promastigote amastigote form iL infantumi inducing metabolic disruption cell death even strain naturally infected dogs finding highlight OEOs potential alternative treatment VL",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Leishmania infantum",
            "Oils, Volatile",
            "Reactive Oxygen Species",
            "Origanum",
            "Mitochondria",
            "Leishmaniasis, Visceral",
            "Antiprotozoal Agents",
            "Dog Diseases",
            "Brazil",
            "Inhibitory Concentration 50",
            "Amphotericin B",
            "Humans",
            "Macrophages"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40606630/",
        "source_type": "Global"
    },
    {
        "pmid": "40604779",
        "title": "The effect of educational intervention on preventive behaviors against cutaneous leishmaniasis in employees of Shiraz special economic zone subsidiary companies.",
        "abstract": "Leishmaniasis major public health veterinary challenge Mediterranean countries Preventing infection critical measure educational intervention utilized modify preventive behavior cutaneous leishmaniasis CL Therefore study aimed evaluate effect educational intervention preventive behavior CL employee Shiraz Special Economic Zone subsidiary companies experimental study conducted 280 employee Shiraz Special Economic Zone subsidiary companies Iran 20232024 140 participant control group 140 intervention group Data collected using questionnaire included demographic information awareness assessment construct Health Belief Model HBM preventive behavior CL questionnaire completed group three month intervention intervention group attended eight educational sessions held weekly lasting 5060 min each mean age intervention group 4038 ± 678 years control group 3892 ± 716 years Results showed significant change mean score Health Belief Model construct intervention group educational session P  005 Additionally significant change observed mean score perceived susceptibility P  0001 perceived barrier P  0001 selfefficacy P  0001 cue action P  0001 intervention control group intervention P  005 result demonstrated applying Health Belief Model beneficial effective enhancing preventive behavior CL approach practical promoting health individual risk",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Adult",
            "Iran",
            "Male",
            "Female",
            "Health Education",
            "Middle Aged",
            "Surveys and Questionnaires",
            "Health Knowledge, Attitudes, Practice",
            "Health Behavior",
            "Health Belief Model"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40604779/",
        "source_type": "Global"
    },
    {
        "pmid": "40604450",
        "title": "A clinico-epidemiological study, assessing possible predictors of mortality and health-related quality of life for people living with visceral leishmaniasis - human immune virus (VL-HIV) co-infection in a high burden kala-azar endemic state of India: a descriptive cross-sectional study.",
        "abstract": "Visceral leishmaniasishuman immunodeficiency virus VLHIV coinfection emerged serious concern could adversely affect VL elimination effort country patient poor VL therapeutic success rate drugrelated toxicity relapse resulting high mortality Despite emerging pattern VLHIV coinfection limited study analyzing presentation VLHIV coinfection Bihar India present study investigated clinicoepidemiological features predictor mortality quality life people living VLHIV coinfection crosssectional study conducted using retrospective data VLHIV case 2018 2020 semistructured questionnaire used data collection Data analysis done using IBM SPSS statistic v22 study included large sample 222 VLHIV cases onefifth patient 47 21 died highly statistically significant difference P  00001 mortality observed male 38 809 female 9 191 death occurred rapidly within mean duration 67 month 95 CI 5481 VL diagnosis highly statistically significant difference P  00001 observed individual stopped antiretroviral therapy ART 36 766 taking ART regularly 11 234 term mortality primary predisposing factor observed heterosexual behavior accounted 113 case 883 case 953 diagnosis done tertiary care center home district majority VL case 101 789 treated multiple dos liposomal amphotericin B 128 VLHIV cases 120 937 declared cured VL completing treatment Approximately 47 case 367 experienced two VL relapses significant difference observed gender income per month environmental health domain specifically present study document time gap initiation cessation ART well duration VL treatment death suggests regular adherence ART may significant impact reducing mortality relapses Therefore comprehensive peoplecentric approach specific group must adopted VLHIV patients Additional epidemiological study VLHIV coinfection warranted",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "India",
            "Male",
            "Cross-Sectional Studies",
            "Female",
            "HIV Infections",
            "Adult",
            "Coinfection",
            "Retrospective Studies",
            "Quality of Life",
            "Middle Aged",
            "Young Adult",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40604450/",
        "source_type": "Global"
    },
    {
        "pmid": "40601159",
        "title": "Integrated diagnosis and successful treatment of imported old world cutaneous leishmaniasis with intralesional sodium stibogluconate in china: a case report.",
        "abstract": "study present case 54yearold woman otherwise healthy presented 4month history red plaque central ulceration initially developed painless papules lesion appeared right arm trunk two month travel Morocco Physical examination revealed 7 cm × 5 cm red plaque central ulceration crusting right arm along papule plaque trunk Based microbiological histopathological PCR results patient diagnosed Old World cutaneous leishmaniasis receiving two session intralesional pentavalent antimonial treatment patient left minor scar experienced negligible side effects except moderate aching therapy",
        "mesh_terms": [
            "Humans",
            "Female",
            "Leishmaniasis, Cutaneous",
            "Middle Aged",
            "Antimony Sodium Gluconate",
            "Antiprotozoal Agents",
            "China",
            "Treatment Outcome",
            "Morocco",
            "Travel",
            "Injections, Intralesional",
            "Communicable Diseases, Imported"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40601159/",
        "source_type": "Global"
    },
    {
        "pmid": "40600094",
        "title": "Unusual Presentation of Pemphigus Vulgaris as a Solitary Ulcerative Scalp Lesion: A Case Report.",
        "abstract": "Pemphigus vulgaris PV rare autoimmune blistering disease typically present painful oral erosion followed widespread cutaneous involvement report diagnostically challenging case PV 43yearold man initially presented solitary ulcerativecrusted lesion parietal scalp evolving eight months lesion clinically suggestive infectious neoplastic etiologies including tinea capitis squamous cell carcinoma Bowens disease leishmaniasis Empirical antifungal treatment ineffective mycological study negative Dermoscopy revealed yellow crusts serpentine vessels perifollicular whitish halos patient later developed painful oral ulcers led histopathological immunofluorescence study confirming PV Systemic corticosteroid mycophenolate mofetil initiated marked clinical improvement case highlight uncommon presentation PV delayed diagnosis emphasizes importance considering autoimmune bullous disorder differential diagnosis chronic nonhealing scalp lesions even absence mucosal involvement",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40600094/",
        "source_type": "Global"
    },
    {
        "pmid": "40600021",
        "title": "A Century of Epidemiological Advances in Cutaneous and Visceral Leishmaniasis in Algeria.",
        "abstract": "Leishmaniasis group disease transmitted sandflies affecting human animals three clinical presentations cutaneous mucosal visceral disease caused parasite iLeishmaniai significant global health issue approximately two million case annually 350 million people risk disease endemic 98 countries including Algeria hotspot Algeria three specie iLeishmaniai iLeishmania majori iLeishmania infantumi iLeishmania tropicai cause cutaneous visceral leishmaniasis cutaneous one highly endemic Algeria since 19th century research leishmaniasis intensive review aimed compiling century research provide updated knowledge transmission diagnosis treatment epidemiology country",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40600021/",
        "source_type": "Global"
    },
    {
        "pmid": "40597737",
        "title": "Molecular detection of Leishmania major human infections in the Zinder area, Niger.",
        "abstract": "Cutaneous Leishmaniasis CL underreported SubSaharan Africa study reported use molecular diagnostic method CL region whereas report therapeutic outcome scarce international consortium established local team Zinder region Niger referral centre leishmaniasis French Guiana Specific training CL diagnostic provided Guianese team Nigerien health workers consenting patient clinically suspected CL lesion enrolled Samples made parasitological smear PCR cotton swabs Then participant treated per local protocol oral metronidazole 14 day followed 4 months total 59 clinically suspected CL case included among 33 56 confirmed PCR andor microscopy including 21 men 22 women 23 minor 10 adults 32 97 presented ulcer including 12 ulcer nodules median number lesion 2 IQR 13 frequent location lesion lower limb 2133 636 followed upper limb 1433 424 One mucosal involvement reported unconfirmed PCR efficacy oral metronidazole 909 3033 among confirmed case 763 4559 overall study population documented specie Leishmania major first report PCRproven human CL Niger first report human CL case Zinder area century Molecular technique confirmed circulation L major area determined isoenzymes analysis Presenting CL patient young Treatment outcome metronidazole encouraging prompt formal evaluation efficacy drug ideally randomized controlled trial",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Leishmania major",
            "Adult",
            "Leishmaniasis, Cutaneous",
            "Niger",
            "Child",
            "Young Adult",
            "Adolescent",
            "Metronidazole",
            "Middle Aged",
            "Polymerase Chain Reaction",
            "Antiprotozoal Agents",
            "Child, Preschool",
            "Infant",
            "Aged",
            "Molecular Diagnostic Techniques"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40597737/",
        "source_type": "Global"
    },
    {
        "pmid": "40597735",
        "title": "Investigation of chronic limb ulcers in Northern Cameroon: a socio-anthropological and clinical perspective.",
        "abstract": "September 2023 fifty case chronic limb ulcer unknown origin reported six Health Districts HDs Northern Cameroon disease locally called Ladde described mystical origin transmitted insect bites aimed describe cases identify cause socioanthropological considerations conducted mixed descriptive crosssectional study November 2023 case person presented skin ulcer four limb least 4 week time study period suspected infectious cause contamination associated condition residing study area January 2018 October 2023 active casefinding health facility within community featured sociodemographic sex age occupation clinical location signssymptoms ulcer occurrence therapeutic data itinerary treatment outcome collected blood samples ulcer swab skin biopsy test pathogen Haemophilus ducreyi Treponema pallidum Mycobacterium ulcerans Mycobacterium leprae Leishmania performed entomological survey search potential vector conducted socioanthropological survey individual interview focus group discussions explore community perceptions identified 153 case total 119 778 men median age 385 year 9 month 94 years Farmers n  63 412 followed housewife n  24 157 affected lower limb n  138 902 preferred location Pain n  130 850 swelling n  113 739 ulceration n  43 281 fever n  42 275 frequent signssymptoms beginning 79 516 cases ulcer occurred spontaneously 67 438 trauma road injuries blunt object ulcers treatment 129 843 case visited traditional healer ordered decoction n  98 641 poultice n  95 621 using powder 81 529 case visited health facility received Cloxacillin n  78 51 diclofenac n  70 458 Ten 65 case completely cured Six ninetyfour 64 case tested HIV positive 8 85 syphilis positive referred appropriate care Dermohypodermatitis n  14 28 50 pyogenic granuloma n  12 28 43 main anatomopathological findings patient positive Mycobacterium ulcerans Haemophilus ducreyi Treponema pallidum pertenue entomological investigation reveal potential insect vector leishmaniasis Socioanthropological survey mostly reported Ladde disease diabolic origin caused spirit come demonpossessed animal tree Posttraumatic leg ulcer dermohypodermatitis predominant clinical anatomopathological patterns Traditional practitioner main point care Strengthening capacity health laboratory personnel diagnosis management chronic skin ulcer pathogen recommended improve outcome chronic ulcers",
        "mesh_terms": [
            "Humans",
            "Cameroon",
            "Male",
            "Female",
            "Cross-Sectional Studies",
            "Adult",
            "Middle Aged",
            "Chronic Disease",
            "Young Adult",
            "Adolescent",
            "Aged",
            "Skin Ulcer",
            "Child",
            "Aged, 80 and over",
            "Extremities"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40597735/",
        "source_type": "Global"
    },
    {
        "pmid": "40596278",
        "title": "AI-driven analysis by identifying risk factors of VL relapse in HIV co-infected patients.",
        "abstract": "Visceral Leishmaniasis VL also known KalaAzar pose significant global public health challenge neglected disease relapse treatment failure leading increased morbidity mortality study introduces explainable machine learning approach predict VL relapse identify critical risk factors thereby aiding patient monitoring treatment strategies Leveraging data followup study 571 patients survival machine learning model applied including Random Survival Forest RSF Survival Support Vector Machine SSVM eXtreme Gradient Boosting XGBoost relapse prediction result demonstrated RSF Cindex 085 outperformed conventional Cox Proportional Hazard CPH model Cindex 08 offering improved prediction capability capturing nonlinear relationship variable interactions address lack transparency in term feature importance Machine Learning ML models SHapley Additive exPlanation SHAP method employed enhances model interpretability feature importance visual insights SHAP dependence plot allowed healthcare professional evaluate factor encourage occurrence relapse statistically significant relationship HIV coinfection HR392 95 CI203758 VL relapse identified 2 loglikelihood ratio chisquare tests result indicate promise explainable artificial intelligence XAI making clinical decision remedying recurrence VL",
        "mesh_terms": [
            "Humans",
            "Risk Factors",
            "HIV Infections",
            "Recurrence",
            "Male",
            "Female",
            "Coinfection",
            "Leishmaniasis, Visceral",
            "Adult",
            "Machine Learning",
            "Support Vector Machine",
            "Middle Aged",
            "Proportional Hazards Models"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40596278/",
        "source_type": "Global"
    },
    {
        "pmid": "40592578",
        "title": "Photoresponsive Carbon Dots Decorated with Nitric Oxide Donors: Synergistic Antiparasitic Action via NO Release and Oxidative Stress.",
        "abstract": "Visceral leishmaniasis VL caused iLeishmania donovanii iLdi lethal vectorborne disease untreated Antimonial drugs effective due ROSgenerating ability largely ineffective due rising antimony resistance iLeishmaniai species accentuating urgent need appropriate therapies Here developed nanocarbon dot decorated flutamidebased nitric oxide donor bNCDNOb which upon visible light activation simultaneously generates singlet oxygen sup1supOsub2sub nitric oxide NO disrupts parasite metabolism sup1supOsub2sub induces oxidative stress together creating synergistic antiparasitic effect Biological study validated dual gas release bNCDNOb mitigates cytotoxic effect seen sup1supOsub2sub generated exclusively nitric oxide donor bNODb nanocarbon dot bNCDb Intracellular parasite clearance assay revealed bNCDNOb achieves significantly higher parasite elimination abating macrophage toxicity selectively eradicating iLeishmaniai amastigotes without impairing host cells",
        "mesh_terms": [
            "Oxidative Stress",
            "Nitric Oxide",
            "Nitric Oxide Donors",
            "Carbon",
            "Leishmania donovani",
            "Animals",
            "Antiprotozoal Agents",
            "Biocompatible Materials",
            "Mice",
            "Quantum Dots",
            "Parasitic Sensitivity Tests",
            "Materials Testing",
            "Particle Size",
            "Light",
            "Macrophages",
            "Antiparasitic Agents",
            "RAW 264.7 Cells"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40592578/",
        "source_type": "Global"
    },
    {
        "pmid": "40590608",
        "title": "Development of shotgun metabolomic profile analysis for detecting canine visceral leishmaniasis using flow-through pinhole paper spray mass spectrometry.",
        "abstract": "Visceral leishmaniasis bVLb neglected infectious disease transmitted dog humans work novel flowthrough pinhole paper spray mass spectrometry bMSb technique described detect metabolite might up downregulated canine VL infection flowthrough pinhole paper spray MS allows direct analysis dried sample prepared paper substrates without prior sample pretreatment Here clinical canine serum sample ten dog positive VL prepared embossed hydrophobic paper substrate lab Similar dried serum sample uninfected control dog prepared embossed paper Partial least square discriminant analysis performed positiveion mode full mass spectrum recorded 20 samples showed significant separation VL positive negative samples Volcano plot confirmed presence several up downregulated specie infected dog samples Results work demonstrate detectable metabolomic change measured canine VL dried serum sample without sample preparation",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Leishmaniasis, Visceral",
            "Metabolomics",
            "Dog Diseases",
            "Paper",
            "Mass Spectrometry",
            "Discriminant Analysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40590608/",
        "source_type": "Global"
    },
    {
        "pmid": "40590280",
        "title": "Humanised Mice in Cutaneous Leishmaniasis-T-Cell Recruitment Into Human Skin Transplants After Leishmania major Infection.",
        "abstract": "Treatment leishmaniasis associated severe side effects high costs parasitic resistance Preclinical model humanised mouse would aid therapeutic improvement development vaccine developed model human skin transplant immunodeficient mouse infected Leishmania major Parasite inoculation skin transplant led robust infection increasing number parasite skin visceral organs addition intraperitoneally coadministered allogeneic peripheral blood mononuclear cell PBMCs strongly recruited skin lesions ≥ 65 cell positive antihuman CD45 identified 20 CD4supsup 50 CD8supsup human cells number skinresident macrophage dendritic cell unaltered compared healthy skin prior transplantation PBMC administration alter numbers Together show parasitic infection provides strong inflammatory signal lead recruitment cell skin transplants presence antigenpresenting cell transplantsas important prerequisite proper APCTcell interactionrecreates fully human skin microenvironment allows stromaimmune cell interaction upon infection model may high interest researcher interested translating skin research question human system vivo",
        "mesh_terms": [
            "Animals",
            "Leishmaniasis, Cutaneous",
            "Humans",
            "Leishmania major",
            "Mice",
            "Skin Transplantation",
            "Disease Models, Animal",
            "Skin",
            "Leukocytes, Mononuclear",
            "Female",
            "CD4-Positive T-Lymphocytes",
            "CD8-Positive T-Lymphocytes",
            "Mice, SCID",
            "T-Lymphocytes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40590280/",
        "source_type": "Global"
    },
    {
        "pmid": "40589799",
        "title": "Clinical Profiles and Outcomes of rK39-Confirmed Paediatric Visceral Leishmaniasis at a General Hospital in Massawa, Eritrea: A Retrospective Study.",
        "abstract": "Although timely diagnostic treatment modality exist worldwide disease Visceral leishmaniasis VL still sporadic outbreak case reported especially high burden SubSaharan countries purpose identify characteristics distribution clinical parameter treatment outcome VL among affected child younger five year old retrospective cohort study design used involving patient admitted rk39 serology diagnosed patient VL treatment center 15th December 2021 7th February 2023 Massawa evaluated patients hospital stay progressive change finally assessing treatment outcome favorable unfavorable study found 97 rk39 confirmed VL cases these case male 536 median age IQR 32 1566 months Ghelalo 62 Foro 351 Northern Red Sea region Eritrea mortality rate 144 14 97 cases younger case found higher mortality rate Children recovered favorable outcome found better baseline hematologic parameters without concomitant infection blood product given Pre post treatment anthropometric hematologic comparison showed significant positive shift p  0001 paired sample iTitest Finally timetoevent analysis revealed 1729 day followup period overall mortality 63 per 1000 childdays Along implementation updated diagnostic treatment guidelines study discovered need regionspecific approach disease holistic treatment approach including nutritional status focusing specific sociodemographic factors strongly affect outcome patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40589799/",
        "source_type": "Global"
    },
    {
        "pmid": "40588734",
        "title": "Expression and immunogenicity evaluation of a novel Lentiviral multi- epitope vaccine against Leishmania major in BALB/c mice.",
        "abstract": "Nowadays prevention parasitic disease including leishmaniasis particularly cutaneous leishmaniasis smost common type disease increased health concern around world Although drug Glucantim Amphotericin B approved side effects Therefore treatment without side effect priority study recombinant lentiviral vaccine containing novel multiepitope KMP11 HASPB Leishmania major L major synthesized multiepitope construct previously designed silico subcloned pCDH513 lentiviral vector recombinant lentiviral multiepitope vaccine rLVmultiepitope synthesized HEK293T cell using packaging vectors Western Blotting method used confirm gene expression Then rLVmultiepitope vaccine injected twice along two control groups phosphate buffered saline PBS rLVempty immunize BALBc mice Twentyone day second injection splenocytes mouse isolated stimulated L major lysate Also serum level IgG1 IgG2a gamma interfron IFNγ interleukin4 IL4 assessed using enzymelinked immunoassay ELISA test result enzymelinked immunoassay ELISA showed titer IFNγ IL4 increased immunized group Also level IFNγ higher significantly compared IL4 result Th1 response generated main group Additionally humoral immune response assessed indicating titer IgG2a IgG1 antibody serum immunized mouse increased compared control groups Moreover serum level IgG2a IgG1 increased main group Therefore humoral immune response increased also positive effect increasing Th1 response result revealed immunization novel rLVmultiepitope vaccine could stimulate immune system toward Th1 increasing production IFNγ IgG2a opsonin antibody",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40588734/",
        "source_type": "Global"
    },
    {
        "pmid": "40588301",
        "title": "Visceral leishmaniasis concealed under a diagnosis of haemophagocytic lymphohistiocytosis.",
        "abstract": "Diagnosing secondary haemophagocytic lymphohistiocytosis sHLH requires systematic approach avoid potentially fatal consequences young man 30s residing northwestern part India presented u fever poor appetite weight loss 3 months Primary evaluation regional hospital showed patient hepatosplenomegaly pancytopenia treating team considered diagnosis primary HLH treated etoposidebased regimen rapid clinical deterioration nonresponsiveness therapy referred centre pursued possibility sHLH repeated bone marrow examination showed iLeishmania donovanii body haemophagocytosis Thereafter patient prescribed liposomal amphotericin B unfortunately succumbed illness case reiterates infection frequent trigger sHLH diagnosis primary HLH adult considered excluding putative infectious causes particularly tropical regions",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Lymphohistiocytosis, Hemophagocytic",
            "Male",
            "Adult",
            "Amphotericin B",
            "Fatal Outcome",
            "Diagnosis, Differential",
            "Leishmania donovani",
            "Antiprotozoal Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40588301/",
        "source_type": "Global"
    },
    {
        "pmid": "40572095",
        "title": "How Common Is Imported Cutaneous Leishmaniasis in Romania? Two Case Reports.",
        "abstract": "Leishmaniasis vectorborne zoonotic disease caused protozoa genus iLeishmaniai endemic Mediterranean Basin Balkans Romania remains nonendemic country However climate change increased international travel documented presence competent vector iPhlebotomusi spp raised concern potential emergence autochthonous cases report two case imported cutaneous leishmaniasis CL diagnosed central Romania region without previously confirmed human animal cases first case involved 31yearold male recent travel history Spain presenting erythematous papule plaque evolved ulcerated lesions diagnosis confirmed histopathologically PCR Treatment miltefosine effective minimal hepatic toxicity sustained response sixmonth followup second case concerned 11yearold boy traveled Elba Italy developed ulcerative lesion progressed rapidly complicated iPseudomonas aeruginosai superinfection Despite initially negative smear PCR testing skin lesion confirmed presence CL Antifungal therapy fluconazole led clinical improvement treatment ongoing time publication case highlight diagnostic therapeutic challenge associated CL nonendemic settings varied clinical evolution underscore importance considering leishmaniasis differential diagnosis chronic nonhealing cutaneous lesions particularly patient travel history endemic regions Increased awareness among clinicians supported accurate diagnostic tool public health surveillance essential identify manage imported leishmaniasis Given absence licensed vaccine growing risk vector expansion Eastern Europe case support WHOs inclusion leishmaniasis among priority neglected tropical disease targeted intensified global control effort 2030",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40572095/",
        "source_type": "Global"
    },
    {
        "pmid": "40561298",
        "title": "Miltefosine implementation for treatment of cutaneous leishmaniasis: access indicators in the state of Minas Gerais, 2021-2024.",
        "abstract": "describe evaluate initial indicator pilot implementation miltefosine Minas Gerais treatment cutaneous leishmaniasis descriptive crosssectional study based regulatory document secondary administrative data generated dispensing miltefosine Minas Gerais May 2021 April 2024 Indicators related access operability strategy implemented calculated step involved approving request use dispensing drug authorization rate 975 281 valid requests outpatient clinic René Rachou Institute reference center leishmaniasis Minas Gerais responsible largest number request period health macroregions Centre North concentrated largest number request 489 336 coincided region highest number reported cases Median time analyzing request person access medicine 10 076 100 0340 days significant variation health macroregions One hundred nineteen people treated municipality place residence these 49 needed travel another health macroregion miltefosine diffusion rate 113 threeyear period monitored significant variation macroregions indicator confirmed miltefosine implemented revealed low diffusion regional disparities Barriers need identified strategy developed expand equitable access new technologies",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Cross-Sectional Studies",
            "Antiprotozoal Agents",
            "Phosphorylcholine",
            "Brazil",
            "Health Services Accessibility",
            "Male",
            "Female",
            "Pilot Projects",
            "Adult",
            "Middle Aged",
            "Child",
            "Adolescent",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40561298/",
        "source_type": "Global"
    },
    {
        "pmid": "40560960",
        "title": "Evaluation of sugar meal administered anti-Leishmania compounds on the vectorial capacity of the vector, Lutzomyia longipalpis.",
        "abstract": "Multiple strategy involving parasitehostvector triad necessary control leishmaniasis One option prevent reduce transmission pathogen phlebotomine sand fly vectors sense essential explore compound may influence vectorial capacity insect reduce longevity investigated effect antiLeishmania drug administered via sugar meal longevity blood feeding oviposition parasite load third day infection sand flies identify promising candidate vector infection tests identified compound affected longevity sand fly three pterocarpanquinones  LQB475 LQB181 LQ03 one hydroxyethylpiperazine PMIC4 Pentamidine reduced oviposition female blood feeding LQB181 PMIC4 decrease infection rate parasite loads result provide effect antiparasitic drug perspective insect vector",
        "mesh_terms": [
            "Animals",
            "Psychodidae",
            "Insect Vectors",
            "Female",
            "Leishmania",
            "Oviposition",
            "Sugars",
            "Longevity",
            "Feeding Behavior",
            "Antiprotozoal Agents",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40560960/",
        "source_type": "Global"
    },
    {
        "pmid": "40559773",
        "title": "Commentary on the Issue of <i>Leishmania</i> Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects.",
        "abstract": "Leishmaniasis infectious disease caused several parasitic specie iLeishmaniai mainly transmitted bite infected phlebotomine sandflies Humans dogs rodents domestic wild animal act reservoir host different iLeishmaniai species neglected tropical disease endemic Asia Middle East North East Africa Mediterranean region South Central America Clinical manifestation disease severity depend specie infecting parasite immunity status host iLeishmaniai represses protective host immune response manipulating macrophage function subverting cytokine expression favor survival dissemination balance proinflammatory regulatory cell necessary bring positive outcome Accurate diagnosis effective treatment represent cornerstone control disease although difficult environment precariousness poverty recent study highlighted progressing work diagnosis treatments development new benzimidazoletriazole derivative blocking parasite growth feline leishmaniasis comparison immune response cat dogs transglutaminase purified iL infantumi result study could open new avenue combating leishmaniasis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40559773/",
        "source_type": "Global"
    },
    {
        "pmid": "40559561",
        "title": "Beyond Mosquitoes: A Review of Pediatric Vector-Borne Diseases Excluding Malaria and Arboviral Infections.",
        "abstract": "Vectorborne disease VBDs significantly impact global child health mosquitotransmitted infection like malaria arbovirus accounting substantial portion burden However arthropodborne diseasestransmitted vector ticks fleas sand flies lice triatomine bugsalso pose serious health risk child worldwide review specifically excludes mosquitoborne disease concentrate lessdiscussed yet clinically important pediatric VBDs examine clinical manifestations diagnostic challenges treatment options highlighting unique vulnerability children including immature immune systems behavioral factors communication barrier delay diagnosis Additionally explore environmental anthropogenic factors climate change urbanization expanding geographic range vectors leading emergence disease like Lyme disease leishmaniasis new regions focusing nonmosquito VBDs review aim raise awareness inform healthcare provider public health practitioner comprehensive landscape pediatric vectorborne diseases",
        "mesh_terms": [
            "Humans",
            "Vector Borne Diseases",
            "Animals",
            "Child",
            "Arbovirus Infections",
            "Arthropod Vectors",
            "Mosquito Vectors",
            "Culicidae",
            "Malaria"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40559561/",
        "source_type": "Global"
    },
    {
        "pmid": "40557324",
        "title": "Evaluation of Beauvericin's activity and mode of action against all life stages of <i>L. tropica</i> for cutaneous Leishmaniasis therapy.",
        "abstract": "Leishmaniasis particularly cutaneous form caused iLeishmania tropicai remains significant global health concern due limitation current treatments including drug resistance toxicity inconsistent efficacy study investigates potential Beauvericin BEA fungal secondary metabolite alternative antileishmanial agent study investigates potential Beauvericin BEA fungal secondary metabolite alternative antileishmanial agent assessed efficacy BEA different developmental stage iL tropicai using iin vitroi assay iin vivo Galleria mellonellai infection model ability iL tropicai develop resistance BEA effect parasites gene expression profile also examined BEA exhibited potent antileishmanial activity equipotency across promastigote amastigote stage iL tropicai ICsub50sub value 025 µM 027 µM respectively significantly lower miltefosine Mechanistically BEA act calcium ionophore inducing marked increase intracellular calcium levels serf primary cytotoxic event Transcriptomic profiling revealed BEAinduced calcium dysregulation trigger secondary cellular response involving calcium homeostasis lipid metabolism stress response contributing multifaceted mechanism action iG mellonellai model demonstrated BEA significantly reduced parasite burden improved survival rates Notably BEA showed slower rate resistance development compared ML indicating potential sustainable treatment option BEA promising candidate antileishmanial therapy demonstrating superior efficacy broad mechanism action favorable resistance profile compared ML investigation mammalian model warranted validate BEAs potential novel costeffective treatment leishmaniasis",
        "mesh_terms": [
            "Leishmania tropica",
            "Animals",
            "Leishmaniasis, Cutaneous",
            "Antiprotozoal Agents",
            "Disease Models, Animal",
            "Depsipeptides",
            "Inhibitory Concentration 50",
            "Life Cycle Stages",
            "Gene Expression Profiling",
            "Drug Resistance"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40557324/",
        "source_type": "Global"
    },
    {
        "pmid": "40556744",
        "title": "DNA damage in canine leishmaniasis infection is detectable by micronucleus and comet assay in peripheral blood samples.",
        "abstract": "iLeishmania infantumi parasite cause leishmaniasis visceral clinical manifestations considered zoonosis infect human animals Currently highly effective treatment available many animal exhibit symptom ultimately die result disease complications clinical sign leishmaniasis varied nonspecific main symptom severe anemia thrombocytopenia weight loss splenomegaly lymphadenomegaly liver disease kidney failure skin lesions among others Due chronic inflammatory state caused parasite oxidative environment created leading potential cell injury damage infected animals genetic material investigate DNA damage conducted micronucleus test comet assay well measured serum LDH level infected noninfected dogs result indicate infected dog present significantly higher level serum LDH 4614 ± 2045 UL n36 compared healthy dog 14238 ± 3794 UL n5 Additionally DNA infected dog damaged control group demonstrated micronucleus test p001 comet assay p0002 finding suggest iLeishmania infantumi infection lead clastogenic events highlighting need research process important consider potential mutagenic property iLeishmania infantumi given ability cause DNA damage infected animals",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40556744/",
        "source_type": "Global"
    },
    {
        "pmid": "40554535",
        "title": "Direct agglutination test: Evolution and significance as a simple and safe alternative to tissue aspiration procedures in the diagnosis of visceral leishmaniasis.",
        "abstract": "Although tissue aspiration procedure TAPs considered gold standard visceral leishmaniasis VL diagnosis often fail detect disease progression amastigotedemonstrable phase overcome limitation primary direct agglutination test DAT developed using intact Leishmania donovani promastigotes initially treated trypsin antigen enhance exposure specific epitope promastigote surface antibodybinding sites alternative proteolytic agent evaluated incorporated antigen processing test execution approach led significant complete inhibition agglutination known crossreacting disorders LQDAT consistently demonstrated highly reproducible result across diverse geographical regions regardless L donovani subspecies strain facilitate routine implementation local production LQDAT processing knowhow disseminated major VLendemic areas Sensitivities comparable TAP outcome demonstrated 2224 2697 VL case successfully diagnosed treated 35 year routine epidemic outbreak evaluations Notably 473 175 case symptomatic TAPnegative LQDATpositive results responded favorably 980100 specific treatment Given lower sensitivity also demonstrated LQDAT TAP meet criterion classification goldstandard VL diagnostic Consequently positive response specific antileishmanial treatment recommended benchmark diagnostic reliability Beyond advantage detecting VL earlier stage compared TAP improved LQDAT described also exhibited feasibility stability required local production lowresource settings",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Humans",
            "Leishmania donovani",
            "Agglutination Tests",
            "Antigens, Protozoan",
            "Male",
            "Female",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40554535/",
        "source_type": "Global"
    },
    {
        "pmid": "40551960",
        "title": "Cutaneous Rosai-Dorfman Disease: A Report of 2 Cases and a Review of Recent Literature (2018-2023).",
        "abstract": "RosaiDorfman disease RDD rare benign histiocytic disorder present isolated cutaneous RDD CRDD often mimicking dermatologic condition complicating diagnosis report two case CRDD one palm sol involvement another exophytic facial mass initially misdiagnosed unsuccessfully treated Dermoscopy revealed distinctive features including yellow ovoid structures linear vessels cottonlike white globules Histopathological immunohistochemical analysis confirmed CRDD histiocytic infiltration emperipolesis key histological marker CRDD review 53 case 20182023 highlight CRDDs clinical variability common anatomical sites diverse treatment responses emphasizing need individualized management early recognition optimal treatment finding contribute broader understanding CRDD support multidisciplinary approach optimizing patient care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40551960/",
        "source_type": "Global"
    },
    {
        "pmid": "40551927",
        "title": "Squamous Cell Carcinoma in Chronic Cutaneous Leishmaniasis: Coincidence or Malignant Transformation.",
        "abstract": "report case 69yearold man developed squamous cell carcinoma SCC site chronic cutaneous leishmaniasis CL lesion dorsum left hand lesion persisted three year despite multiple local systemic treatments Histopathological examination confirmed diagnosis welldifferentiated SCC patient lost followup year returned locally advanced disease ultimately requiring hand amputation case underscore potential malignant transformation chronic leishmaniasis lesion highlight need timely biopsy longterm monitoring atypical nonhealing ulcer endemic regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40551927/",
        "source_type": "Global"
    },
    {
        "pmid": "40550412",
        "title": "Repurposing of propafenone, an FDA approved anti-arrhythmic drug for antileishmanial therapy.",
        "abstract": "Elimination Neglected Tropical Disease Visceral Leishmaniasis VL Sustainable Development Goal caused Leishmania donovani therapeutic option treatment VL limited due problem drug resistance toxicities Drug repurposing promising alternative case work antileishmanial potential FDA approved antiarrhythmic drug propafenone evaluated repurposing reduced viability L donovani promastigotes intracellular amastigotes ICsub50sub 825 ± 248 μM 1119 ± 001 μM respectively macrophages ICsub50sub 32 ± 707 μM Propafenone treatment altered morphology parasite induced damage body flagellum cell membrane became damaged permeable promastigotes treated drug However change cell membrane potential detected Treatment propafenone detrimental mitochondrial health L donovani significantly depolarized mitochondrial membrane decreased ATP level promastigotes Propafenone also induced oxidative stress parasites Cell cycle arrest detected Gsub2subM stage data suggests propafenone antileishmanial potential evaluated experimental VL model",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40550412/",
        "source_type": "Global"
    },
    {
        "pmid": "40550305",
        "title": "Upregulation of nicotinamide/nicotinate mononucleotide adenylyl transferase increases resistance to oxidative stress and antimony in promastigotes of Leishmania braziliensis.",
        "abstract": "Leishmaniasis prevalent parasitic neglected disease caused protozoan genus Leishmania Currently vaccine available humans existing treatment ineffective toxicity emergence drugresistant strains Consequently crucial identify new potential therapeutic targets thereby facilitating development effective therapies study indicates correlation upregulated biosynthesis nicotinamide adenine dinucleotide NAD resistance hydrogen peroxide Hsub2subOsub2sub trivalent antimony exposure Sbsup3sup L braziliensis promastigotes CRISPRCas9 geneediting nicotinamidenicotinate mononucleotide adenylyl transferase L braziliensis Lbnmnat key gene NAD biosynthetic pathway allowed upregulation mRNA protein levels well elevated NAD NADP content Lbnmnatedited parasites single guide RNA template directed 5 end Lbnmnat donor DNA consisting mCherry reporter gene preceded 5 UTR Crithidia fasciculata phosphoglycerate kinase CfPGKB electroporated L braziliensis promastigotes constitutively express Streptococcus pyogenes Cas9 T7 RNA polymerase PCR analysis DNA sequencing demonstrated successful editing Lbnmnat gene Importantly dosedependent oxidative stress susceptibility assay Hsub2subOsub2sub Sbsup3sup revealed higher ICsub50sub value Lbnmnatedited parasites finding denote correlation upregulated biosynthesis NAD L braziliensis enhanced resistance oxidative stress indicating Lbnmnat gene may play significant role survival resistance mechanism parasite antimony compounds",
        "mesh_terms": [
            "Oxidative Stress",
            "Up-Regulation",
            "Nicotinamide-Nucleotide Adenylyltransferase",
            "Leishmania braziliensis",
            "Antimony",
            "Hydrogen Peroxide",
            "NAD",
            "CRISPR-Cas Systems",
            "Gene Editing",
            "Antiprotozoal Agents",
            "Animals",
            "NADP",
            "RNA, Messenger",
            "Drug Resistance"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40550305/",
        "source_type": "Global"
    },
    {
        "pmid": "40548752",
        "title": "Pentamidine inhibition of streptopain attenuates <i>Streptococcus pyogenes</i> virulence.",
        "abstract": "obligate human pathogen iStreptococcus pyogenesi also known GAS Group iStreptococcusi carry high morbidity mortality primarily impoverished resourcepoor regions failure rate monotherapy conventional antibiotic high invasive infection bacterium frequently require extensive supportive care surgical intervention Thus important find new compound adjunctive therapeutic benefits conserved secreted protease streptopain Streptococcal pyogenic exotoxin B SpeB directly contributes disease pathogenesis inducing pathological inflammation degrading tissue promoting evasion antimicrobial host defense proteins study screened 400 diverse offpatent drug druglike compound inhibitor streptopain proteolysis Lead compound tested activity lower concentration antivirulence activity iin vitroi infection Significant inhibition streptopain seen pentamidine antiprotozoal drug approved treatment Pneumocystis pneumonia leishmaniasis trypanosomiasis Streptopain inhibition rendered GAS susceptible killing human innate immune cells study identify unexploited molecule new starting point drug discovery potential repurposing existing drug treatment infection GASIMPORTANCEiStreptococcus pyogenesi common cause severe invasive infections Repeated infection trigger autoimmune disease acute rheumatic fever rheumatic heart disease study examines targeting specific highly conserved virulence factor secreted cysteine protease streptopain sensitize serious pathogen killing immune system Manipulating hostpathogen interaction rather attempting directly kill microbe promising therapeutic strategy Notably benefit include limiting offtarget effect microbiota Streptopain inhibitors including antifungal antiparasitic drug pentamidine identified work may therefore useful treatment iS pyogenesi infection",
        "mesh_terms": [
            "Streptococcus pyogenes",
            "Humans",
            "Exotoxins",
            "Virulence",
            "Pentamidine",
            "Streptococcal Infections",
            "Bacterial Proteins",
            "Anti-Bacterial Agents",
            "Virulence Factors",
            "Cysteine Endopeptidases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40548752/",
        "source_type": "Global"
    },
    {
        "pmid": "40547705",
        "title": "Lipid-Based Nanocarriers for Topical Therapy of Cutaneous Leishmaniasis: An Insight into the Mechanism of Action.",
        "abstract": "Cutaneous leishmaniasis CL parasitic infection caused Leishmania species affecting million worldwide current treatment option CL several limitations including low efficacy inability reach target site potential toxicity longer treatment duration leading poor patient compliance Therefore urgent need alternative treatments especially topical ones effective safe patientfriendly Although numerous review described advantage wide range nanoparticles treatment CL review narrow focus utilization novel lipidbased nanocarriers topical treatment CL offering indepth analysis topical potential mechanism skin permeation lipidic nanocarriers Lipidbased nanostructures liposomes solid lipid nanoparticles nanostructured lipid carrier extensively studied CL treatment either alone combination drug therapies carrier improve bioavailability stability efficacy drug target infected site reduce adverse effect healthy tissues Moreover easily formulated different dosage forms creams gels ointments convenient topical application Despite many benefit lipidbased carriers still challenge need addressed optimizing formulation parameters ensuring reproducibility scalability process evaluating longterm safety efficacy clinical trials study aim provide comprehensive overview current stateoftheart lipidbased nanocarriers topical treatment CL covering recent advances limitations clinical evidence prospect promising approach addition skin macrophage targeting potential various lipidbased nanocarriers also discussed especially helpful treating lesion CL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40547705/",
        "source_type": "Global"
    },
    {
        "pmid": "40546545",
        "title": "The Treatment of Acute Cutaneous Leishmaniasis With Oral Zinc Bisglycinate and Oral Hydroxychloroquine Sulfate.",
        "abstract": "Background objective Cutaneous leishmaniasis CL one significant endemic parasitic infection many region around world caused several specie Leishmania parasite morbid condition lead stigmatization disfiguring scars Numerous method tried treat leishmaniasis variable cure rate side effects study aimed compare effect oral zinc bisglycinate ZnGly oral hydroxychloroquine sulfate HCQ alone combination treating acute CL Materials method comparative therapeutic study conducted Center Dermatology Venereology Medical City Baghdad Iraq period December 2021 February 2023 participant diagnosed history clinical examination involved skin smear patient skin biopsy suspicious cases Patients classified three group based type treatment Group treated oral ZnGly capsule 50 mg twice daily eight weeks Group B administered oral HCQ tablet 200 mg twice daily eight weeks Group C received combination drug eight weeks patient examined every four week eight weeks followed every month two month stopping therapy treatments impact lesion assessed using Sharquies modified Leishmania score Results total 40 patient acute CL included study spanned eight weeks total number lesion 144 duration ranged five 12 weeks Group included 14 patients cure rate 786 11 Group B included 13 patients cure rate 847  11 Group C included 13 patients cure rate 923 12 observed statistically significant difference cure rate Group C compared Group Group B end study p0034 Conclusions oral ZnGly HCQ monotherapy effective treatment acute CL combination regimen drug led higher effectiveness without increase frequency adverse effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40546545/",
        "source_type": "Global"
    }
]